9 month 28 Today, Frost & Sullivan Frost & Sullivan Co-hosted by Frost & Sullivan, LeadLeo and Huajun Media Group, with the participation of Titanium Media and Roadshow in China. 2022 The inaugural New Investment Expo and the 16th Frost & Sullivan Global Growth, Innovation and Leadership Summit BioTech Investment Forum successfully concluded.   Today, the biotechnology sector has become a dazzling pearl in the capital market. The opening of the Hong Kong Stock Exchange and the Sci-Tech Innovation Board to unprofitable enterprises has further catalyzed a capital boom. However, due to unfavorable macroeconomic factors in recent years and structural challenges faced by biotechnology companies themselves, the performance of biotechnology companies in the capital market varies. Therefore, how to discover new tracks and seize new opportunities in an environment where crises coexist has become a hot topic among investors and entrepreneurs.   The forum, themed 'New Trends in Biotech Investment and Financing', invited eight heavyweight guests and three Frost & Sullivan healthcare industry experts. It brought together a multitude of biotech companies, investment institutions, and professional service providers to jointly focus on new trends in biotech investment and financing, explore forward-looking investment opportunities in biotechnology, and discuss the successful paths of biotech companies in the capital market.    At the same time, Frost & Sullivan's Global 2022 Biotechnology Growth, Innovation and Leadership Awards (abbreviation: GIL Award-winning enterprises.   Dr. Wang Xin, Global Partner at Frost & Sullivan and President of Greater China, Founder and Chairman of LeadLeo, delivered a welcome speech for the conference, which was grandly opened. Dr. Wang Xin stated that over the past decade or so, the development of biotech companies in China has essentially been about 'crossing the river by feeling the stones'. The rapid market explosion started with 2018 Released by the Hong Kong Stock Exchange 18A chapter. and   Capital investment is an indispensable and important factor in driving the growth of biotech companies, and it is crucial for promoting research and development and accelerating commercial success in the life sciences industry.   He pointed out that in the face of the inevitable cyclical nature of the industry, to find more certain investment opportunities in the biopharmaceutical field, it is necessary to conduct long-term and continuous in-depth research on technological trends, policy changes, and industry dynamics in the biotechnology sector.   Frost & Sullivan's Healthcare practice is based in China. 60 The remaining analyst team has been dedicated to in-depth industry and enterprise research for a long time, enabling seamless integration while helping to meet the supply and demand sides of investment and financing.   Dr. Wang Xin, Global Partner and President of Frost & Sullivan Greater China Region, Founder and Chairman of LeadLeo, delivered a speech at the conference.     Discovering Hidden Dragons in High-Potential Tracks:   2022 Announcements of Annual Biotech Growth, Innovation and Leadership Awards At the meeting, Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China Region, Co-founder and President of LeadLeo, delivered speeches on the awards won this year respectively. GIL Beijing Zehui Chenxing Biotechnology Co., Ltd. was awarded the 'Global Multi-Potent Stem Cell Drug Leadership Award', and Chongqing Jinshan Medical Robot Co., Ltd. was presented with the 'China Medical Robotics Innovation Award". Beijing Zehui Chenxing Biotechnology Co., Ltd. CMO Dr. Jia Yi takes the stage to receive his award Ms. Wang Liao, founder of Chongqing Jinshan Medical Robotics Co., Ltd., took the stage to receive her award   Focus on Biotechnology Hotspots: CDMO The white paper "Industrial Current Situation and Future Development Trends Report" is officially released Mr. Li Dongyi, Director of Healthcare Consulting at Frost & Sullivan, delivered a grand launch of CDMO company Industrial Current Situation and Future Development Trend Report》, which aims at China CDMO Conduct an in-depth analysis of the industry, exploring various aspects such as industry overview, capital enthusiasm, and competitive landscape. CDMO Explore the industry value, investigate the driving force factors and trends behind industry development, and track the iterative context of production technology.   This report focuses on CDMO While the overall industry operation is performing well, focus on each CDMO company The current development status of segmented fields, in China and globally CDMO The overall industry landscape and key tracks were analyzed for market size, reflecting past China CDMO The development history of each sub-field, as well as for the future CDMO Forecast the future prospects of market growth space. We would like to express our special gratitude to Kanglong Chemical Technology, Dongyao Pharmaceutical, and Yaohai Biotechnology for their support of this report. Kang Long Huacheng Securities' General Supervising Officer Yang (left), Dongyao Pharmaceutical's Financial Director Xiao Ben (middle), and Wang Manchao, Founder Partner, Director and General Manager of Yaohai Biotechnology (right).     Three major professional topics, discussing the development and future of the biotechnology investment and financing market The first session of the conference was delivered by Mr. Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China, who shared the theme of 2022 Review and Prospect of the Biomedical Investment and Financing Market in 2023 Mr. Mao Hua said that the biopharmaceutical capital market has not entered a winter period, and the investment and financing market tends to be 'prudent'. + Rationality: Investors tend to invest earlier, targeting smaller companies with more hardcore technology. This provides certain room for maneuver for investment institutions, and even in the early stages, they still offer high valuations to tech-intensive enterprises. In addition, Mr. Mao Hua also stated that industrial capital has emerged as a new force, and the professional investment institutions and financing relay mechanism are gradually being improved, promoting the healthy development of the biotechnology industry.   Mr. Mao Hua summarized that investment and financing, as well as enterprise operations, complement each other. In the past, products reached clinical trials II In the future, enterprises need to plan pricing, sales strategies after product launch, and at what discount rates they can enter into medical insurance. Now, enterprises need to go a step further by making early plans during financing. Partner and Managing Director, Greater China, Frost & Sullivan Mr. Mao Hua Dr. Wang Shu, Deputy General Manager of Yikelei Biotechnology, shared the theme 'Because We Believe Therefore, upon seeing 'A Brief Discussion on Synthetic Biology', Dr. Wang Shu systematically organized the definition, research content, and industry overview of synthetic biology. He pointed out that synthetic biology has opened a new era in scientific research, and its application potential is gradually emerging. The core technology of synthetic biomanufacturing is to construct efficient microbial cell factories. All pathways need to be assembled, balanced, and optimized within this factory to achieve results, thereby converting biomass raw materials into various end products. How to expand the variety of chemicals produced by microbial cells and how to improve cell production efficiency are currently two very critical issues limiting the industrialization of cell factories.   Dr. Wang Shu stated that synthetic biology is a field that many countries have attached great importance to in recent years, especially driven by carbon neutrality. The competitiveness of synthetic biology is gradually emerging, and its future development potential cannot be underestimated. Vice General Manager of Yikelei Biotechnology Dr. Wang Shu Mr. Zhu Jielun, Chief Financial Officer and Chief Investment Officer of Feipeng Group, delivered a keynote speech titled "How Biotech Companies Efficiently Meet Their Financing Needs." He believes that the essence of the capital market is an amplifier, and participants generally have a herd mentality, leading to phenomena such as following trends and magnifying them. At the same time, he believes that in the vast ocean of the capital market, discovering, grasping, and utilizing cycles is the key to success.   Finally, Mr. Zhu Jielun summarized the high-quality IR The qualities required include the ability to manage expectations externally, integrate information internally, possess a sincere trait, and also convey real-time market capitalization information within departments. Chief Financial Officer and Chief Investment Officer of Feipeng Group Mr. Zhu Jielun     Roundtable Discussion: Exploring the New Pattern of Industry Development   A roundtable forum was specially set up at this summit, where leaders and experts from multiple companies shared their industry experiences and insights on hot topics such as how biotech companies choose diverse listing locations.   Mr. Ren Mengqi, Executive General Manager of Investment Banking at CICC, Mr. Geng Ke, Managing Partner at Meimes Law Firm, Mr. Fei Fan, Co-Head of Life Sciences and Healthcare at EY Greater China, Mr. Li Ankang, Chief Financial Officer and Chief Strategy Officer at Tengsheng Bo Pharmaceutical, and Mr. Wang Shuguang, Managing Partner and General Manager at Shanghai Wen Zhou Investment Management Co., Ltd., engaged in an in-depth discussion around 'hot topics such as how biopharmaceutical technology companies choose diverse listing locations'. Mr. Zhu Yi, Executive Director of Frost & Sullivan, served as the moderator for this roundtable. Mr. Ren Mengqi, Executive General Manager of Investment Banking at CICC, stated that although the capital market has recently entered a low point, it has also given investors time to calm down and identify what truly constitutes a good company. Mr. Geng Ke, Managing Partner of Meimas Law Firm, mentioned recent bills and cases affecting the capital market of the biotech industry, pointing out that the review of Chinese companies acquiring US companies has become increasingly stringent. Mr. Fei Fan, Co-Head of Life Sciences and Healthcare at EY Greater China, mentioned that against the backdrop of an overall pessimistic environment, companies need to achieve 'wait, save, and integrate'. First, they should wait for the macro environment to improve, then save cash by keeping it safe and making full use of it, and finally integrate it. Although companies now face issues such as declining valuations when financing, they still need money to operate. Mr. Li Ankang, Chief Financial Officer and Chief Strategy Officer of Tengsheng Boyao, stated that there are many uncertainties in the current market, and businesses need to adjust their business priorities. In addition, it is necessary to raise the standards for doing business and products, as enterprises are facing a more competitive market and more discerning investors under the current macro environment. Mr. Wang Shuguang, the managing partner and general manager of Shanghai Wen Zhou Investment Management Co., Ltd., stated that his institution is engaged in earlier-stage investments and has not experienced difficulties in financing or a severe winter-like environment. As an investment institution, it is necessary to prioritize investment research, understand national policy trends, and identify companies whose products truly have clinical advantages.   In addition, as one of the representatives of the partners, Mr. Zhou Yujian, managing partner of Power Health Fund Management, sent his blessings to the conference via video. Mr. Zhou Yujian stated that Power Health Fund is honored to work with Frost & Sullivan to play a role in the global development layout and joint efforts of Chinese biopharmaceutical enterprises. PowerHealth Fund Management Partnership Mr. Zhou Yujian The conference successfully concluded amidst warm applause. We would like to express our gratitude to all the distinguished guests and experts for their support of the Frost & Sullivan Biopharmaceutical Technology Investment Forum.

9 month 28 Today, Frost & Sullivan Frost & Sullivan Co-hosted by Frost & Sullivan, LeadLeo and Lianyuan Media Group, with the participation of Tencent Cloud 2022 The inaugural New Investment Expo and the 16th Frost & Sullivan Global Growth, Innovation and Leadership Summit BioTech Investment Forum successfully concluded.   Today, the biotechnology sector has become a dazzling pearl in the capital market. The opening of the Hong Kong Stock Exchange and the Sci-Tech Innovation Board to unprofitable enterprises has further catalyzed a capital boom. However, due to unfavorable macroeconomic factors in recent years and structural challenges faced by biotechnology companies themselves, the performance of biotechnology companies in the capital market varies. Therefore, how to discover new tracks and seize new opportunities in an environment of coexisting crises has become a hot topic among investors and entrepreneurs.   The forum, themed 'New Trends in Biotech Investment and Financing', invited eight heavyweight guests and three Frost & Sullivan healthcare industry experts. It brought together numerous biotech companies, investment institutions, and professional service providers to jointly focus on the new trends in biotech investment and financing, explore forward-looking investment opportunities in biotechnology, and discuss the successful paths of biotech enterprises in the capital market.    At the same time, Frost & Sullivan's Global 2022 Biotechnology Growth, Innovation and Leadership Awards for the Year (abbreviation: GIL Award-winning enterprises.   Dr. Wang Xin, Global Partner at Frost & Sullivan and President of Greater China, Founder and Chairman of LeadLeo, delivered a welcome speech for the conference, which was grandly opened. Dr. Wang Xin stated that over the past decade or so, the development of biotech companies in China has essentially been about navigating through unknown waters, with the rapid market explosion starting from 2018 Released by the Hong Kong Stock Exchange 18A chapter. And   Capital investment is an indispensable and important factor in driving the growth of biotech companies, and it is crucial for promoting research and development and accelerating commercial success in the life sciences industry.   He pointed out that in the face of the inevitable cyclical nature of the industry, to find more certain investment opportunities in the biopharmaceutical field, it is necessary to conduct long-term and continuous in-depth research on technological trends, policy changes, and industry dynamics in the biotechnology sector.   Frost & Sullivan's Healthcare Practice has offices in China 60 The remaining analyst team has been dedicated to in-depth industry and enterprise research for a long time, enabling seamless integration while helping to meet the supply and demand sides of investment and financing.   Dr. Wang Xin, Global Partner at Frost & Sullivan and President of Greater China, Founder and Chairman of LeadLeo, delivered a speech at the conference     Discovering Hidden Dragons in High-Potential Tracks:   2022 Announcements of Annual Biotech Growth, Innovation and Leadership Awards At the meeting, Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China Region, Co-founder and President of LeadLeo, delivered his views on this year's achievements respectively. GIL Beijing Zehui Chenxing Biotechnology Co., Ltd. was awarded the 'Global Multi-Functional Stem Cell Drug Leadership Award', while Chongqing Jinshan Medical Robotics Co., Ltd. received the 'China Medical Robotics Innovation Award'. Beijing Zehui Chenxing Biotechnology Co., Ltd. CMO Dr. Jia Yi took the stage to receive his award Ms. Wang Liao, founder of Chongqing Jinshan Medical Robotics Co., Ltd., took the stage to receive her award     Focus on Biotechnology Hotspots: CDMO company The white paper "Industrial Current Situation and Future Development Trends Report" is officially released Mr. Li Dongyi, Director of Healthcare Consulting at Frost & Sullivan, delivered a grand launch of CDMO Industrial Current Situation and Future Development Trend Report》, which aims at China CDMO Conduct an in-depth analysis of the industry, exploring various aspects such as industry overview, capital enthusiasm, and competitive landscape. CDMO Explore the industry value, investigate the driving force factors and trends behind industry development, and track the iterative context of production technology.   This report focuses on CDMO While the overall industry is operating in this manner, we focus on each CDMO The current development status of segmented fields, in China and globally CDMO The overall industry landscape and key tracks were analyzed for market size, reflecting past in China CDMO The development history of each sub-sector, and their outlook for the future CDMO company Forecast the future prospects of market growth space. We would like to express our special gratitude to Kanglong Chemical Technology, Dongyao Pharmaceutical, and Yaohai Biotechnology for their support of this report. Kanglong Huacheng Securities' General Supervising Officer Yang (left), Dongyao Pharmaceutical's Financial Responsible Person Xiao Ben (middle), and Wang Manchao, Founder Partner, Director and General Manager of Yaohai Biotechnology (right).     Three major professional topics, discussing the development and future of the biotechnology investment and financing market The first session of the conference was delivered by Mr. Mao Hua, Partner and Managing Director of Frost & Sullivan Greater China, who shared the theme of 2022 Review and Prospect of the Biomedical Investment and Financing Market in 2023 Mr. Mao Hua said that the biopharmaceutical capital market has not entered a winter period, and the investment and financing market tends to be 'prudent'. + Rationality: Investors tend to invest earlier, targeting smaller companies with more hardcore technology. This provides certain room for maneuver for investment institutions, and even in the early stages, they still offer high valuations to tech-intensive enterprises. In addition, Mr. Mao Hua also stated that industrial capital has emerged as a new force, and the professional investment institutions and financing relay mechanism are gradually being improved, promoting the healthy development of the biotechnology industry.   Mr. Mao Hua summarized that investment and financing, as well as enterprise operations, complement each other. In the past, products reached clinical trials II In the future, enterprises need to plan pricing, sales strategies after product launch, and at what discount rates they can enter into medical insurance. Now, enterprises need to go a step further by making early plans during financing. Partner and Managing Director of Frost & Sullivan Greater China Region Mr. Mao Hua Dr. Wang Shu, Deputy General Manager of Yikelei Biotechnology, shared the theme 'Because We Believe Therefore, upon seeing 'A Brief Discussion on Synthetic Biology', Dr. Wang Shu systematically organized the definition, research content, and industry overview of synthetic biology. He pointed out that synthetic biology has opened a new era in scientific research, and its application potential is gradually emerging. The core technology of synthetic biology manufacturing is to construct efficient microbial cell factories. All pathways need to be assembled, balanced, and optimized within this factory to achieve results, thereby converting biomass raw materials into various end products. How to expand the variety of chemicals produced by microbial cells and how to improve cell production efficiency are currently two very critical issues restricting the industrialization of cell factories.   Dr. Wang Shu stated that synthetic biology is a field that many countries have attached great importance to in recent years, especially driven by carbon neutrality. The competitiveness of synthetic biology is gradually emerging, and its future development potential cannot be underestimated. Vice General Manager of Yikelei Biotechnology Dr. Wang Shu Mr. Zhu Jielun, Chief Financial Officer and Chief Investment Officer of Feipeng Group, delivered a keynote speech titled "How Biotech Companies Efficiently Meet Their Financing Needs." He believes that the essence of the capital market is an amplifier, and participants generally have a herd mentality, following trends and magnifying them. At the same time, he believes that in the vast ocean of the capital market, discovering, grasping, and utilizing cycles is success.   Finally, Mr. Zhu Jielun summarized the high-quality IR The qualities required include the ability to manage expectations externally, integrate information internally, possess a sincere trait, and be able to convey real-time market capitalization information within departments. Chief Financial Officer and Chief Investment Officer of Feipeng Group Mr. Zhu Jielun   Roundtable Discussion: Exploring the New Pattern of Industry Development   A roundtable forum was specially set up at this summit, where leaders and experts from multiple companies shared their industry experiences and insights on hot topics such as how biotech companies choose diverse listing locations.   Mr. Ren Mengqi, Executive General Manager of Investment Banking at CICC, Mr. Geng Ke, Managing Partner at Meimes Law Firm, Mr. Fei Fan, Co-Head of Life Sciences and Healthcare at EY Greater China, Mr. Li Ankang, Chief Financial Officer and Chief Strategy Officer at Tengsheng Bo Pharmaceutical, and Mr. Wang Shuguang, Managing Partner and General Manager at Shanghai Wen Zhou Investment Management Co., Ltd., engaged in an in-depth discussion on 'hot topics such as how biopharmaceutical technology companies choose diverse listing locations'. Mr. Zhu Yi, Executive Director of Frost & Sullivan, served as the host of this roundtable. Mr. Ren Mengqi, Executive General Manager of Investment Banking at CICC, stated that although the capital market has recently entered a low point, it has also given investors time to calm down and identify what truly constitutes a good company. Mr. Geng Ke, Managing Partner of Meimas Law Firm, mentioned recent bills and cases affecting the capital market of the biotech industry, pointing out that the review of Chinese companies acquiring US companies has become increasingly stringent. Mr. Fei Fan, Co-Head of Life Sciences and Healthcare at EY Greater China, mentioned that against the backdrop of an overall pessimistic environment, companies need to achieve 'wait, save, and integrate'. First, they should wait for the macro environment to improve, then save cash by keeping it safe and making full use of it, and finally integrate. Although companies may face issues such as declining valuations when financing now, they need money to continue operations. Mr. Li Ankang, Chief Financial Officer and Chief Strategy Officer of Tengsheng Boyao, stated that there are many uncertainties in the current market, and businesses need to adjust their business priorities. In addition, it is necessary to raise the standards for doing business and products, as enterprises are facing a more competitive market and more discerning investors in the current environment. Mr. Wang Shuguang, the managing partner and general manager of Shanghai Wen Zhou Investment Management Co., Ltd., stated that his institution is engaged in earlier-stage investments and has not experienced difficulties in financing or the arrival of a severe winter market. As an investment institution, it needs to prioritize investment research, understand national policy trends, and identify companies whose products truly have clinical advantages.   In addition, as one of the representatives of the partners, Mr. Zhou Yujian, managing partner of PowerSquare Health Fund Management, sent his blessings to the conference via video. Mr. Zhou Yujian stated that PowerSquare Health Fund is honored to work with Frost & Sullivan to contribute to the globalization development and layout of Chinese biopharmaceutical enterprises, and to jointly make efforts. PowerHealth Fund Management Partnership Mr. Zhou Yujian The conference successfully concluded amidst warm applause. We would like to express our gratitude to all the distinguished guests and experts for their support of the Frost & Sullivan Biopharmaceutical Technology Investment Forum.

2022 year 9 month 27 On the same day, Frost & Sullivan & LeadLeo's Science and Technology Innovation Expert Committee appointment ceremony was held in 2022 The inaugural New Investment Expo and the 16th Frost & Sullivan Global Growth, Innovation and Leadership Summit were grandly held.   On September 27, 2022, the Appointment Ceremony of the Frost & Sullivan's LeadLeo's Expert Committee on Innovation was held during the 1st New Investment Expo and the 16th Frost & Sullivan Growth, Innovation and Leadership Summit. Frost & Sullivan, in collaboration with LeadLeo Research Institute, has established a Science and Technology Innovation Expert Committee. The aim is to gather authoritative institutions from industry, academia, research, and capital as well as cutting-edge scientific and technological innovation forces. It aims to identify emerging future market leaders at an early stage and empower them comprehensively through branding, marketing, talent, capital, etc. Frost & Sullivan and LeadLeo established the Expert Committee on Innovation to bring together authoritative institutions, cutting-edge science and technology innovation forces from industry, university, academia and capital circles, aiming to identify future market leaders and empower them to grow in various aspects such as brand, market, talent and capital. The membership of the Frost & Sullivan & LeadLeo Science and Technology Innovation Expert Committee is very comprehensive, including representatives from outstanding listed company entrepreneurs, authoritative academic and research institutions, investment institutions, and professional organizations. 30 A senior professional with significant industry influence. The panel members of Frost & Sullivan's LeadLeo's Expert Committee on Innovation come from different professions, each making significant impacts and contributions to their respective industries. The committee has nearly 30 members, including outstanding listed company entrepreneurs, academic and research institutions, capital market participants, and professional service providers.   The following is the specific list of members of the Frost & Sullivan & LeadLeo Science and Technology Innovation Expert Committee: The following is the list of Frost & Sullivan's LeadLeo Expert Committee on Innovation : Entrepreneur Representative   Enterprise Representatives   Chief Executive Officer, InnoCentric Intelligence Dr. Xu Hui   Dr. Xu Hui, CEO of AInnovation Chairman of Rilian Technology Dr. Liu Jun   Dr. Liu Jun, Chairman of Unicomp Technology   Co-founder and CEO of Hesai Technology Dr. Li Yifan   Li Yifan, Co-founder and CEO of Hesai Technology Founder of Yushi Technology Mr. Wu Gansha   Mr. Wu Gansha, Founder of UISEE   Chairman of Wanxue Education Technology Group Mr. Zhang Rui   Mr. Zhang Rui, Chairman of Universal Education Group   Vice President of Shangtang Technology Mr. Tang Zhenyi   Mr. & Coach Tang, Vice President of SenseTime Vice President of Healthcare Culture and Tourism Finance Business Unit, Ping An Bank Mr. Ji Wen Mr. Ji Wen, Deputy President of Ping An Bank's Healthcare Culture Tourism Finance Department Chief Financial Officer and Chief Investment Officer of Feipeng Group Mr. Zhu Jielun   Mr. Zhu Jielun, CFO and CIO of Fapon Biotech   Founder of Himalaya Gold Service Mr. Wang Mutian   Mr. Wang Mutian, Founder of Himalaya Financial Information Service   * Rankings are not in any particular order.   Representatives from academic and research institutions   Representatives from Academic and Research Institutions Doctoral supervisor at Shenzhen University, Dean of the Microelectronics Research Institute at Shenzhen University, and Dean of the Semiconductor Manufacturing Research Institute Professor Wang Xujin   Wang Xujin, Doctoral Supervisor of Shenzhen University, President of Microelectronics Research Institute, and President of Semiconductor Manufacturing Research Institute of Shenzhen University Secretary-General of the Innovation and Entrepreneurship Education Steering Committee for Higher Education Institutions of the Ministry of Education, Doctoral Supervisor at Tongji University, Executive Deputy Dean of the Innovation and Entrepreneurship College at Tongji University Professor Zhou Bin   Zhou Bin, Professor    Secretary-General of the Innovation and Entrepreneurship Education Steering Committee of the Ministry of Education, Doctoral Supervisor of Tongji University, Executive Vice-President of the School of Innovation & Entrepreneurship of Tongji University   Doctoral supervisor at Fudan University, Deputy Dean of the School of Management at Fudan University Professor Lv Changjiang   Lv Changjiang, Professor and Doctoral Supervisor at Fudan University, Vice-President of the School of Management at Fudan University   Person in charge of the National-level Mass Innovation Demonstration Base, Director of the Practice Center at Xi'an Jiaotong University, and Deputy Dean of the Innovation and Entrepreneurship College Professor Chen Libin   Chen Libin, Director of the School of Innovation & Entrepreneurship, Vice President of the School, and Head of the National Innovation Demonstration Base, and also the Director of the Practical Teaching Center   Deputy Director of the Innovation Center and Executive Deputy Dean of the School of Innovation and Entrepreneurship at Sichuan University Dr. Wu Di   Dr. Wu Di, Deputy Director of Innovation Center and Executive Vice President of School of Innovation & Entrepreneurship, Sichuan University   Member of the Employment and Entrepreneurship Education Steering Committee for Graduates from Regular Higher Education Institutions of the Ministry of Education, Deputy General Manager of Zhonggang High-tech (Beijing) Investment Management Co., Ltd. Dr. Jin Yaoguang   Dr. Jin Yaoguang, Member of the Employment and Entrepreneurship Education Steering Committee of the Ministry of Education, Vice General Manager of SINSTEEL Hitech Invesment   * Rankings are not in any particular order.   Representatives of investment institutions   Representatives from the Investment Community Senior Partner of Yuanhe Chenkun Mr. Li Huaijie   Mr. Li Huaijie, Senior Partner of Oriza FoFs Investment Management Executive President of Shanghai Science and Technology Innovation Fund Mr. Kang Ming   Mr. Kang Ming, CEO of Shanghai Science and Technology Innovation Center Equity Investment Fund Management Executive Vice President and Managing Director of Jinpu Industrial Investment Fund Management Co., Ltd. Mr. Fan Yin   Fan Ying, Executive Vice President and Managing Director of GP Capital Chairman and Founding Partner of Xingfu Capital Mr. Wang Tingfu   Mr. Wang Tingfu, Chairman of the Board and Founding Partner of Richen Capital Chairman and CEO of Bohai Capital   Mr. Luo Tian   Luo Tian, Chairman of the Board and CEO of BoJiang Capital Chairman of New Silk Road Capital Mr. Wang Maoting   Mr. Wang Maoting, Chairman of the Board of NSR Group Managing Partner of CCL Capital Mr. Huang Guanhua   Mr. Huang Guanhua, Managing Partner of Chuang House Capital * Rankings are not in any particular order.   Representatives of professional institutions   Representatives from Professional Service Institutions Executive Vice President, CCB International Mr. Liu Shoujian   Mr. Liu Shoujian, Executive Vice President of CCB International   Global Director and Vice Chairman of the China Regional Board at Dacheng Law Firm Mr. Wang Changliang   Mr. Wang Shanliang, Global Director and Vice Chairman of the Board of Directors in China of Dentons EY Hong Kong Greater China M&A Services Partner   Mr. He Zhaofeng   Mr. He Zhaofeng, Chief Partner of Listing Services of    EY Greater China     President of China Financial Information Center Mr. Zhang Fengming   Mr. Zhang Fengming, President of China Financial Information Centre   * Rankings are not in any particular order.   It is reported that the Frost & Sullivan & LeadLeo Science and Technology Innovation Expert Committee is chaired by Dr. Xu Hui, with Mr. Wang Changliang serving as the executive committee chairperson and Mr. Zhang Fengming as the secretary-general of the committee.   The Frost & Sullivan LeadLeo's Expert Committee on Innovation is chaired by Dr. Xu Hui, with Mr. Wang Shanliang serving as Chairman of the Executive Committee and Mr. Zhang Fengming serving as Secretary-General of the Committee. At the same time, a Standing Committee is established, which includes Dr. Xu Hui,   Mr. Wang Changliang,   Mr. Zhang Fengming, Mr. Zhu Jielun,   Tang Zhenyi first    born,   Mr. Li Huaijie, Mr. Kang Ming, Mr. Zhang Rui, Dr. Liu Jun.   Meanwhile, we have established a Standing Committee consisting of 9 members: Dr. Xu Hui,   Mr. Wang Shanliang,   Mr. Zhang Fengming, Mr. Zhu Jielun,   Mr. & Coach Tang,   Li Huaijie, Kang Ming, Zhang Rui and Liu Jun, MD. At the appointment ceremony, Dr. Wang Xin, Global Partner and President of Frost & Sullivan Greater China, together with Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, jointly presented appointment certificates to the expert committee members and took a group photo.   At the appointment ceremony, Neil Wang, Global Partner and Greater China President of Frost & Sullivan, and Yves Wang, Managing Partner and Executive Vice President of Frost & Sullivan for Greater China, presented appointment certificates to the expert committees. Dr. Wang Xin and Mr. Wang Chenhui presented appointment certificates to the expert committee members and took a group photo. Dr. Neil Wang and Mr. Yves Wang presented the appointment certificates to the expert committees   In the future, the Frost & Sullivan & LeadLeo Science and Technology Innovation Expert Committee will give full play to its strengths and expertise, pool the wisdom of all sectors, focus on growth, serve growth, and contribute to China's economic development!   In the future, Frost & Sullivan's LeadLeo's Expert Committee on Innovation will give full play to its strengths and expertise, gather wisdom from all walks of life, focus on growth, and serve growth in order to contribute to the economy in China!

2022 year 9 month 27 day,   TIM （ Total Investment Management , All-region investment management)   The launching ceremony is at 2022 The inaugural New Investment Expo and the 16th Frost & Sullivan Global Growth, Innovation and Leadership Summit were grandly held. The 16th Frost & Sullivan Global Growth, Innovation and Leadership Summit, themed 'New Investment', defined what new investment means.   Frost & Sullivan believes that new investment represents a brand-new investment philosophy and methodology, as well as a three-dimensional, multi-dimensional spatial point matrix service system. New investment bears the mission of 'endowing value to corporate capital operations, energizing industry transformation and upgrading, and serving national economic development'. In the past, 'fund raising, investment management, and exit' was a classic investment model. With the reform and upgrading of the capital market, as well as the intensification of competition in the primary market in recent years, investment institutions have become increasingly eager to judge opportunities early and explore targets at an earlier upstream stage.   Dr. Wang Xin, Global Partner at Frost & Sullivan and President of the Greater China Region, as well as Founder and Chairman of LeadLeo, stated that although China has seen an enhanced dynamic of innovative development over the past decade and new progress has been made in building an innovative country, there is still room for further improvement in terms of the quality of science and technology investment from 'large' to 'strong'.   In recent years, the state has placed great emphasis on innovation and technology, and there is enormous long-term growth potential and investment potential for Chinese science and technology innovation enterprises.   "To fully tap the growth potential of science and technology innovation enterprises and accelerate their growth rate requires the joint efforts and collaboration of all sectors of society. In particular, the support from the capital market is crucial, and everyone needs to work together to create a ' Fundraising, Investment and Disposal ' An upgraded version of the classic investment model. 'Dr. Wang Xin said. Global Partner and President of Frost & Sullivan Greater China, Founder and Chairman of LeadLeo   Dr. Wang Xin   Against this backdrop, Frost & Sullivan has joined hands with representatives from various sectors to launch a three-dimensional, multi-dimensional spatial point cloud-based service system...     " TIM （ Total Investment Management ), namely, All-region Investment Management"    We are committed to creating an ecological service system covering the entire lifecycle and entire industrial chain of enterprises. By internalizing and linking a series of service capabilities within the system, including enterprise management, regulatory communication, industry development trend analysis, market and strategic planning, brand value empowerment, etc., we aim to provide better investment management services for enterprises in all aspects. At the launching ceremony, Dr. Wang Xin, Global Partner and President of Frost & Sullivan Greater China Region, Founder and Chairman of LeadLeo; Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China Region, Co-founder and President of LeadLeo; Mr. Li Huaijie, Senior Partner at Yuanhe Chenkun; Mr. Kang Ming, Administrative President of Shanghai Science and Technology Innovation Fund; and Innovent Smart were present. CEO Dr. Xu Hui, Mr. Wang Tingfu, Chairman and Founding Partner of Xingfu Capital, and the Founder of Haishong Capital CEO Mr. Chen Liguang, Managing Partner; Mr. Zhang Fengming, President of China Financial Information Center; and the Founder and CEO Ms. Zhao Hejuan, Mr. Wan Yong, Chairman of YunTech, Ms. Chen Ying, Founder of the Roadshow, and Huajun Media Group CFO Mr. Li Qifeng jointly activated the startup device, witnessing the commencement of the new investment ecosystem with all the attendees present. As of the end of last year, the number of small, medium and micro enterprises across the country reached 4,800 Ten thousand households, compared 2012 Year-end growth 2.7 times, accounting for more than 95% , absorbing more than 80% create GDP exceed 70% However, during the rapid development phase, most startups do not possess a relatively mature business plan or direction of development, and their understanding of policies and industries is relatively superficial. Especially in the first two years of entrepreneurship, which are critical for growth, risks are higher and need to be guarded against. This year, the number of fresh university graduates in China exceeded one million for the first time, setting new historical highs both in scale and increment. Moreover, amidst the 'mass entrepreneurship and innovation' craze, more and more college students are engaging in entrepreneurial practices. However, they also face issues such as financing difficulties, lack of experience, and inadequate services. They similarly need professional institutions to facilitate their career selection, employment, entrepreneurship, and innovation. At the same time, in the face of an uncertain environment, investment institutions need to accurately assess global trends and national policies to find more certain investment opportunities, as well as have a profound understanding of 'good industries' and 'good enterprises'.   "New investments" are dedicated to empowering the unmet needs of enterprises, industries, and society as mentioned above. Frost & Sullivan and LeadLeo have nearly 500 The human analyst team at Frost & Sullivan has long been committed to in-depth industry and corporate original research. Frost & Sullivan has a global presence of over 60 The annually accumulated industry-wide database, reported by LeadLeo and included in the databases of one of the world's largest financial market data and infrastructure providers, Refinitiv, enables precise reachability of reports. 190 country 4 More than 10,000 institutions, 40 For users of the Ten-thousand-Dollar Professional Finance platform, seamless integration is available, building a bridge between both the supply and demand sides of investment and financing. Frost & Sullivan' 60 We have been committed to capital market services for many years and have a relative understanding of what kind of enterprises can succeed IPO listing We enable investors to exit; we also have rich experience in packaging, highlighting investment highlights, and establishing healthy interactions with the capital market.   For enterprises at different development stages, Frost & Sullivan and LeadLeo help them focus on innovation R&D capabilities through initiatives such as the 'Pioneers Program', 'LeadLeo', and 'Best Practice Awards'. They assist in establishing effective investment and financing strategies, talent strategies, industrial ecosystems, and market layouts, thereby building core competitiveness to achieve deeper and more sustained long-term growth.   Dr. Wang Xin pointed out that achieving growth is the top priority for enterprise development, innovation and entrepreneurship are the core driving forces for enterprise development, and becoming a market leader is the lofty goal for an enterprise's long-term success. 'New investments' refer to investing in those enterprises that have already achieved or are expected to demonstrate growth, innovation and leadership in the future.    Frost & Sullivan aims to integrate professional resources, a pool of high-quality targets, capital pools, and expert teams in growth and technology innovation, deeply empowering practitioners of 'new investment'. It helps enterprises achieve growth, empowers industrial transformation and upgrading through technology innovation, cultivates leading Chinese entrepreneurs, and ultimately promotes the economic and social development of China.     In the future, Frost & Sullivan looks forward to working hand in hand with representatives from all sectors, each fulfilling their role to meticulously craft and long-term implement pan-region investment management. This will benefit all stakeholders and contribute to the country's innovative development.

9 month 27 Today, Frost & Sullivan Frost & Sullivan Co-hosted by Frost & Sullivan, LeadLeo and Lianyuan Media Group, with the participation of Tencent Cloud 2022 The 1st New Investment Expo and the 16th Frost & Sullivan Global Growth, Innovation and Leadership ( GIL The Summit (hereinafter referred to as the 'Conference') grandly opened at the Shanghai International Convention Center. The Conference is committed to building the premier platform for corporate investment and financing, facilitating sustainable and high-quality development. The summit brought together nearly a thousand leading enterprises from various industries, a large number of outstanding innovation projects, representatives from governments, investment institutions, financial institutions focusing on industrial development, as well as academicians and scientific research experts. The conference was live-streamed in real time through roadshows and can be viewed on Titanium Media, the video account of the China Financial Information Center, and Orient Fortune. choice Data, iFinCert iFinD Wande 3C Synchronized broadcasts on platforms such as Tianfeng International, TradeGo, Snowball, roadshows, Futu NiuNiu, Xingzheng International, Frost & Sullivan's video account, and LeadLeo's video account. Special thanks to Diamond Partner Yunxing Medical, Platinum Partner Silan Technology, and Innovative Partner Lingsa Cloud for their strong support of this summit. The 16th Frost & Sullivan Global GIL The summit focused on the theme of 'New Investments' for the first time. Dr. Wang Xin, Global Partner at Frost & Sullivan and President of Greater China, Founder and Chairman of LeadLeo, said in his speech at the conference: 2022 The year is a crucial one for the implementation of the "14th Five-Year Plan" and also an era of forging ahead towards the second centenary goal. In the post-pandemic era, how Chinese enterprises can maintain high-quality development, enhance innovation momentum, and seize strategic opportunities are issues that everyone is concerned about. Cultivating and strengthening new drivers represented by new technologies, new industries, new business forms, and new models cannot be separated from the empowerment of industrial capital and the impetus of technological innovation.   "The Frost & Sullivan Summit integrates professional resources, a pool of high-quality targets, capital pools, and expert teams in growth and technology innovation, deeply empowering practitioners of 'new investment'. It helps enterprises achieve growth, empowers industrial transformation and upgrading through technology innovation, cultivates leading Chinese entrepreneurs, and ultimately promotes the economic and social development of China." said Dr. Wang Xin. Dr. Wang Xin, Global Partner at Frost & Sullivan and President of Greater China, Founder and Chairman of LeadLeo, delivered a speech at the conference.   GIL Frost & Sullivan·LeadLeo Science, Technology and Innovation Expert Committee Appointment Ceremony At the meeting, the appointment ceremony for the Frost & Sullivan & LeadLeo Science and Technology Innovation Expert Committee was held in grand style. Frost & Sullivan, in collaboration with the LeadLeo Research Institute, established the Science and Technology Innovation Expert Committee with the aim of bringing together authoritative institutions from industry, academia, research, capital, and cutting-edge science and technology innovation forces to identify emerging future market leaders at an early stage and empower them comprehensively through branding, marketing, talent, capital, etc. Dr. Wang Xin, Global Partner at Frost & Sullivan and President of Greater China, Founder and Chairman of LeadLeo, and Mr. Wang Chenhui, Managing Partner at Frost & Sullivan and Executive Vice President, Co-founder and President of LeadLeo, presented appointment certificates to the committee members. List of Frost & Sullivan·LeadLeo Science and Technology Innovation Experts   Entrepreneurial Representative: Chief Executive Officer, InnoCentric Intelligence Dr. Xu Hui Chairman of Rilian Technology Dr. Liu Jun Co-founder and CEO of Hesai Technology Dr. Li Yifan Founder of Yushi Technology Mr. Wu Gansha Chairman of Wanxue Education Technology Group Mr. Zhang Rui Vice President of Shangtang Technology Mr. Tang Zhenyi Vice President of Healthcare Culture and Tourism Finance Business Unit, Ping An Bank Mr. Ji Wen Chief Financial Officer and Chief Investment Officer of Feipeng Group Mr. Zhu Jielun Founder of Himalaya Gold Service Mr. Wang Mutian Representatives from academic and research institutions: Doctoral supervisor at Shenzhen University, Dean of the Microelectronics Research Institute at Shenzhen University, and Dean of the Semiconductor Manufacturing Research Institute Professor Wang Xujin Secretary-General of the Innovation and Entrepreneurship Education Steering Committee for Higher Education Institutions of the Ministry of Education, Doctoral Supervisor at Tongji University, Executive Deputy Dean of the Innovation and Entrepreneurship College at Tongji University Professor Zhou Bin Doctoral supervisor at Fudan University, Deputy Dean of the School of Management at Fudan University Professor Lv Changjiang Person in charge of the National-level Mass Innovation Demonstration Base, Director of the Practice Center at Xi'an Jiaotong University, and Deputy Dean of the Innovation and Entrepreneurship College Professor Chen Libin Deputy Director of the Innovation Center and Executive Deputy Dean of the School of Innovation and Entrepreneurship at Sichuan University Dr. Wu Di Member of the Employment and Entrepreneurship Education Steering Committee for Graduates from Regular Higher Education Institutions of the Ministry of Education, Deputy General Manager of Zhonggang High-tech (Beijing) Investment Management Co., Ltd. Dr. Jin Yaoguang Representatives of investment institutions: Chairman and Founding Partner of Xingfu Capital Mr. Wang Tingfu Executive President of Shanghai Science and Technology Innovation Fund Mr. Kang Ming Executive Vice President and Managing Director of Jinpu Industrial Investment Fund Management Co., Ltd. Mr. Fan Yin Senior Partner of Yuanhe Chenkun Mr. Li Huaijie Chairman and CEO of Bohai Capital   Mr. Luo Tian Chairman of New Silk Road Capital Mr. Wang Maoting Managing Partner of CCL Capital Dr. Huang Guanhua Representatives of Professional Institutions: Executive Vice President, CCB International Mr. Liu Shoujian Global Director and Vice Chairman of the China Region at Dacheng Law Firm Mr. Wang Changliang EY Hong Kong Greater China M&A Services Partner   Mr. He Zhaofeng President of China Financial Information Center Mr. Zhang Fengming Group photo of (partial) members of the Frost & Sullivan & LeadLeo Science, Technology and Innovation Expert Committee   GIL TIM Global Investment Management Launch Ceremony Through this event, Frost & Sullivan joins hands with representatives from all sectors to kick off   " TIM （ Total Investment Management ), namely the All-region Investment Management ” service system   The aim is to create an ecological service system covering the entire lifecycle and industrial chain of enterprises. By internalizing and linking a series of service capabilities within the system, including enterprise management, regulatory communication, industry development trend analysis, market and strategic planning, brand value empowerment, etc., we provide better investment management services for enterprises in all aspects. At the meeting, Dr. Wang Xin, Partner at Frost & Sullivan and President of Greater China, Founder and Chairman of LeadLeo; Mr. Wang Chenhui, Managing Partner at Frost & Sullivan in Greater China and Executive Vice President, Co-founder and President of LeadLeo; Mr. Li Huaijie, Senior Partner at Yuanhe e kun; Mr. Kang Ming, Executive President of the Shanghai Science and Technology Innovation Fund; and Innovent Smart were present. CEO Dr. Xu Hui, Mr. Wang Tingfu, Chairman and Founding Partner of Xingfu Capital, and the Founder of Haishong Capital CEO Mr. Chen Liguang, Managing Partner; Mr. Zhang Fengming, President of China Financial Information Center; and the Founder and CEO Ms. Zhao Hejuan, Mr. Wan Yong, Chairman of YunTech, Ms. Chen Ying, Founder of the Roadshow, and Huajun Media Group CFO Mr. Li Qifeng jointly activated the startup device, witnessing the beginning of the new investment ecosystem with all the participating guests present. TIM Global Investment Management Launch Ceremony   GIL The research results of "New Investments" are unveiled with great significance At the same time, the main forum on the first day gathered industry insights and investment trend perspectives, covering topics such as macro trends and value investing. On-site announcements included those of China's private equity funds IPO listing Transcript, "Private Equity CFO White Paper on "Digital Transformation Meets the Development Trend of the New Era" and Chinese Private Equity Firms CFO Ranking list, “ chang ·The Frost & Sullivan's 'Global Newcomer 100' list, a heavyweight 'New Investment' research achievement, was released along with the latest industry research report from Frost & Sullivan - 'Independent Market Study on the Robot Mobile Base Industry'.     Chinese private equity fund IPO listing report card   2021 Year, global IPO listing The market has experienced fluctuations, destined to be a year etched in history. , This year, U.S. stocks went "globalization-banning" and became more "Hong Kong-listed feverish times." A share IPO listing New Year. Enterprise IPO listing and so VC/PE investment An important manifestation of investment capability and exit capability, 2021 In [year], who will be the winner IPO listing Most Champions in Enterprises VC/PE investment ?   Against this backdrop, Frost & Sullivan, in collaboration with Titanium Media, has extended an invitation to all active and outstanding domestic investment institutions to jointly launch the 'China Private Equity Fund 2021 annual IPO listing Data collection for the 'Champion Performance Report'. At the main conference forum, Frost & Sullivan, in collaboration with Titanium Media, released 'China Private Equity Firms IPO listing Grade Report", co-founder of Titanium Media Group CEO Ms. Zhao Hejuan delivered a keynote speech and released the ranking list. Founder of Titanium Media Group CEO Ms. Zhao Hejuan     Chinese private equity fund CFO list     Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China Region, Co-founder and President of LeadLeo, and Mr. Kim Dewei, Chairman of Meishang Technology, jointly released 2022 China's Private Equity Fund Industry in CFO White Paper: Private Equity CFO Digital Transformation Meets the Development Trend of the New Era" and “ 2022 annual VC/PE investment Best of the institutions CFO Top10 "The list, and the winners." CFO Award presentation. Managing Partner of Frost & Sullivan Greater China, Co-founder and President of LeadLeo Mr. Wang Chenhui Mr. Wang Chenhui, Managing Partner of Frost & Sullivan Greater China and Co-founder and President of LeadLeo, together with Mr. Kim Dewei, Chairman of Meishit Technology, were awarded CFO Award presentation Mr. Wang Chenhui, Partner-in-Chief of Frost & Sullivan Greater China, Co-founder and President of LeadLeo, is the recipient of the award CFO Award presentation          2022 " chang ·>Set Sail” Global Newcomer Science and Technology Innovation Enterprise List         On the occasion of this year's conference, Frost & Sullivan and LeadLeo Research Institute have jointly launched “ chang ·>Set Sail” - A New Global Frontier in Science and Technology 2022 Selection. This selection focuses on enterprises in the early stages of development, aiming to identify industry leaders with excellent future growth potential, sustainable development capabilities, national and international development prospects, clear competitive advantages, and the potential to lead the way into the future. Partner and Managing Director of Frost & Sullivan Greater China, Co-founder of LeadLeo CEO Mr. Yang Xiaocheng, Secretary-General of the Innovation and Entrepreneurship Education Steering Committee for Higher Education Institutions of the Ministry of Education, and Professor Zhou Bin, Executive Deputy Dean of the Innovation and Entrepreneurship College at Tongji University, jointly released at the conference 2022 " chang Launch the 'Global Newcomer Sci-Tech Enterprise List' and present awards to some of the listed companies. Partner and Managing Director of Frost & Sullivan Greater China, Co-founder of LeadLeo CEO Mr. Yang Xiaocheng, Secretary-General of the Innovation and Entrepreneurship Education Steering Committee for Higher Education Institutions of the Ministry of Education, and Professor Zhou Bin, Executive Deputy Dean of the Innovation and Entrepreneurship College at Tongji University, jointly presented awards to some of the winning enterprises.          The 'Independent Market Research Report on the Robot Mobile chassis Industry' is released       Robots are a manifestation of technological value and an indispensable part of future human life. At the conference, Frost & Sullivan officially released the 'Independent Market Research Report on the Robot Mobile Base Industry'. The report focuses on studying the global robot mobile base market, analyzing growth points in the market, with Mr. Lu Jing, Partner and Managing Director of Frost & Sullivan Greater China, delivering a presentation. Mr. Lu Jing said: 'The robot market is growing rapidly, and the global robot market size is expected to be 2024 Annual achievement 660 billions. The core needs of robots in different scenarios, as well as their practical value in real-world situations, increasingly depend on the robot's autonomous mobility capabilities. Autonomous mobility has become the cornerstone for unlocking the potential of robot applications. Compared to traditional robots, robots with autonomous mobility have a higher level of intelligence and possess significant advantages in environmental perception, positioning and navigation, path planning, motion control, human-machine interaction, device interconnection, and more. The robot's mobile chassis carries multiple functions such as motion control, environmental perception, and positioning and navigation, making it an indispensable part of mobile robots; the development capability of the chassis has become one of the key entry barriers in the autonomous mobility robot industry. As a leading manufacturer of robot mobile chassis, Silan Technology provides software and hardware development integration, production manufacturing, cross-industry know-how in technology We provide a series of leading capabilities such as deployment, operation and maintenance, installation, and debugging services, offering scenario-level, one-stop mobile chassis solutions for downstream application layer vendors. Partner and Managing Director, Greater China, Frost & Sullivan Mr. Lu Jing GIL Wonderful speeches at the main forum The keynote speech session of the main forum included Li Huaijie, Senior Partner at Yuanhe Chenkun, Wang Tingfu, Chairman and Founding Partner of Xingfu Capital, and the founder of Haishong Capital. CEO Co-Managing Partner Chen Liguang, Dr. Huang Guanhua, Head of Partners at Clink Capital, Professor Zhou Bin, Secretary-General of the Innovation and Entrepreneurship Education Steering Committee for Higher Education Institutions under the Ministry of Education, Doctoral Supervisor at Tongji University, Executive Deputy Dean of the Innovation and Entrepreneurship College at Tongji University, Sun Haitao, Chairman of Yunxing Medical, and Silan Technology CEO Chen Shikai, Founder and CEO Zhao Hejuan, Chairman of YunTech Wan Yong, Founder Chen Ying during the roadshow and more than a dozen other representatives from the investment industry, academia, and business, gathered to discuss topics such as capital empowering the development of the real economy, data rainforest empowering investment, investment opportunities in the metaverse, how capital and technology can soar with dual wings, empowering college students' 'mass entrepreneurship and innovation', new opportunities in the medical service industry, intelligent robot innovation practices, and digitization. IR Let's share as the topic unfolds. Mr. Li Huaijie, Senior Partner of Yuanhe Chenkun, said,   A strong tech nation is a long snow-capped slope for future investment, and technological innovation requires the support of equity capital.    The underlying changes in technology and capital will affect and transform the equity investment logic of the primary market, opening a new chapter for equity investments.    A master fund, based on a deep understanding and judgment of the industry, familiarity with primary equity professionals, and grasp of the demands of capital and resource providers, can play a good role as a hub and integrator. Senior Partner of Yuanhe Chenkun Mr. Li Huaijie Mr. Wang Tingfu, Chairman and Founding Partner of Xingfu Capital, pointed out,   Dataization and intelligence are certain investment opportunities for China over the next decade.    In the era of digital economy, data and technology are core production factors.    Dataization can enable users to be precise, operations to be efficient, and decisions to be forward-looking. Data has a multiplier effect in the fields of economy, business, and investment. Chairman and Founding Partner of Xingfu Capital Mr. Wang Tingfu Founder of Seawolf Capital CEO Mr. Chen Liguang, Managing Partner, also proposed,   Policy-driven development has fueled the rapid growth of China's hard technology industry.    China is already the world's leader in multiple sub-sectors of technology.    30 Over the years, rapid development has created a huge middle-class consumer group in China, leading to an increasing demand for high-tech products such as smartphones and new energy vehicles.    china GDP While maintaining a high growth rate, the proportion of research expenditure has been increasing year by year. China's investment has entered a new era, and hard-core technology has risen strongly. Founder of Seawolf Capital CEO Co-Managing Partner Mr. Chen Liguang Dr. Huang Guanhua, Managing Partner of CCL Capital, briefly introduced the metaverse to the guests present—defined as the virtual iteration of the internet, a world that is born from and parallel to the real world, yet influences it. He stated that the metaverse market is currently in a period of rapid short-term growth. In addition to emerging industries, many traditional sectors are also adopting metaverse technology to carry out their operations. More and more industries are entering the metaverse market, and it is expected that the metaverse will become a new growth point in the digital economy, providing a new path for China's digital transformation. Managing Partner of CCL Capital Dr. Huang Guanhua Mr. Wan Yong, Chairman of CloudTech, pointed out that the new generation of black swan and grey rhino events have become the norm. Investment logic is breaking down in search of new patterns, globalization is being replaced by sectoralization. In the future, industrial digitization will become China's best response practice, while new consumption will be the biggest breakthrough for domestic circulation.   Under the impact of reverse globalization, domestic substitution has become a long-term bet on the capital market. Cloud technology is positioned to build a digital ecosystem for listed companies in Hong Kong, encompassing digitalization ( D ), roadshow R ), relational databases ( C ), committed to building a 'data platform' around the needs of listed companies + Communication Platform + Service Platform ”. Chairman of CloudTech Mr. Wan Yong Mr. Sun Haitao, Chairman of Yunxing Medical, stated that China has entered a stage of mild aging, with the degree of population aging continuously deepening. In recent years, China's health sector has made significant progress, with steady advancement in elderly health services, a gradual increase in the proportion of elderly medical care, gradual expansion of elderly health security services, and increasingly active market services for elderly health products. Against this backdrop, China's average life expectancy has been continuously increasing. In the future, medical service institutions will develop towards internationalization, informatization, and quality improvement. Chairman of Yunxing Medical Mr. Sun Haitao   Silan Technology CEO Mr. Chen Shikai delivered his speech from the perspective of a robotics entrepreneur. He pointed out that in recent years, the robotics industry has been continuously booming, with new scenario demands emerging year by year and the number of industry players increasing. Data shows that to 2024 In 2023, the market scale of robots in China is expected to exceed a certain threshold 250 100 billion, with the global robot market size expected to exceed this 660 Yi. At the same time, services, industry, and special fields have seen comprehensive growth, with market segmentation leaders emerging. The overall robot market is on an upward trend, and the industry prospects are promising. Silan Technology CEO Mr. Chen Shikai During the roadshow, Ms. Chen Ying, the founder, delivered a speech focusing on the trends and opportunities of new roadshows. She proposed that The three trends brought about by the new roadshow include: 1 ) From offline to online, Improve communication efficiency; 2 ) From fuzzy to precise, Reduce transaction costs; 3 ) From point-to-point to internet effect, create Create trading opportunities. The three major opportunities include    Direct connection between listed companies and investors, A brand-new listing service portal, Precise matching of massive intent leads. Founder at the Roadshow Ms. Chen Ying Finally, Ms. Ding Zhuowen, President of LeadLeo (Shanghai) Research Institute, said, Focusing value communication on specific scenarios is the precise dissemination of corporate investment value to existing and a wide range of potential investors. Only by continuously implanting the core values of the enterprise into the minds of investors can we shape their future expectations of the company. LeadLeo hopes to achieve this through value communication. 2 A key goal is, first, to enable investors to deeply understand the core value of a company, and second, to help them fully shape positive expectations for the company's future. Dean of LeadLeo (Shanghai) Research Institute Ms. Ting Chau-wen GIL Roundtable Dialogue During the roundtable discussion session, Frost & Sullivan's Partner and Managing Director for Greater China, LeadLeo's co-founder and CEO Hosted by Yang Xiaocheng, Yunxing Medical CEO Mr. Qian Li, Mr. Bai Yang, Partner of PWR Health Fund, and Founder of ZeroSai Cloud CEO Mr. Zhuang Jianwei and Mr. Li Zhile, Chief Financial Officer of Mengke Pharmaceutical, jointly discussed the topic of 'Empowering Industrial Innovation with Capital to Help Enterprises Achieve Stability and Long-term Development'.   Under the chairmanship of Mr. Wang Kaiyue, Editor-in-Chief of the 'White Paper on Investor Relations of Listed Companies in China', Mr. Lu Jinyuan, Chief Information Officer of Qiming Medical, Mr. Zhan Yaohua, Bloomberg China's Investor Relations Specialist, and S&P Global's Corporate Governance and ESG Ms. Zhang Yige, Director of the entire Strategy Service, and Ms. Nie Anna, Head of Investor Relations and Public Affairs at Mengke Pharmaceutical, discussed 'Empowering High-Quality Development through New Trends in Investor Relations'. GIL Frost & Sullivan Best Practice Awards Presentation The Frost & Sullivan Growth, Innovation and Leadership Best Practices Award is designed to recognize outstanding companies that have made significant contributions and achieved leadership positions in various industries. The judging panel consists of experts from various financial institutions and senior executives from leading companies across different sectors. The selection process has been carried out globally for nearly 30 Over the years, the authority and fairness of the awards have been widely recognized by the investment community, financial sector, and within the industry. As of now, a total of 5,000+ Excellent enterprise. At this year's conference, Mr. Wang Chenhui, Partner-in-Chief and Executive Vice President of Frost & Sullivan Greater China, delivered a presentation on the acquisitions made this year GIL Enterprises that have won various awards, including China Mobile Communications Group Yunnan Co., Ltd., Beijing Yingtong Technology Development Co., Ltd., and Zhiben Medical Technology ( shanghai ) Limited Company, ZeroCloud, Zhaobian ( shanghai ) Certifications issued by Technology Co., Ltd., etc. Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, presented the award to YingTong Technology. 2022 China Portable Fundus Camera Market Leadership Award for 2019 Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, is with Zhiben Medical Technology ( shanghai ) The limited company was awarded the 'Leading Platform Award for Precision Diagnosis and Treatment of Digital Oncology in China'. Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, is interviewed by Czero Cloud. LeanCodee/ Model-Driven Low-Code Series Wins the "China Industrial Software Product Innovation Award" Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, presented the 'China Automotive Road Collaboration Technology Innovation Award' to Zhaobian (Shanghai) Technology Co., Ltd.   GIL Signing Ceremony In addition, witnessed by the attending guests, Frost & Sullivan has signed strategic cooperation framework agreements with multiple enterprises to establish long-term strategic cooperative relationships. In the future, all parties will fully leverage their respective resource advantages and carry out more comprehensive cooperation in market development, product research and development, service implementation and promotion, among other areas.   Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, Mr. Wan Yong, Chairman of Frost & Sullivan Jieli (Shenzhen) Cloud Technology Co., Ltd., and Shanghai Tongcai Fu Information Technology Co., Ltd. CEO Mr. Liu Hongju signed strategic cooperation framework agreements with Frost & Sullivan and Yuntongcaifu on behalf of them respectively. In line with the principles of resource sharing and close collaboration, all parties have decided to establish a long-term, stable, and close strategic partnership to jointly achieve value dissemination and promotion for more listed companies and enterprises. With joint efforts, we aim to win-win results and keep moving forward. Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, Mr. Wan Yong, Chairman of Frost & Sullivan Jie Li (Shenzhen) Cloud Technology Co., Ltd., and Mr. Zhen Yimeng, Partner of the Corporate Secretary's Office at Hejun Consulting, signed strategic cooperation framework agreements on behalf of Frost & Sullivan, cloud technology, and Hejun Consulting's Corporate Secretary's Office respectively. In the future, the three parties will cooperate closely and develop together to assist enterprises in solving practical problems, integrate industry with capital, double enterprise value, and jointly empower and contribute to the development of enterprises and the real economy. Frost & Sullivan, Tencent Cloud, Yicai and Zoomlion held a session on 'Jointly Creating One-stop Cross-border IPO listing The strategic cooperation signing ceremony of 'Service Alliance' was held to further consolidate, expand and strengthen the comprehensive business partnership among all parties, and actively explore new cooperation models. Mr. Wang Chenhui, Managing Partner and Executive Vice President of Frost & Sullivan Greater China, Mr. Wan Yong, Chairman of Frost & Sullivan Jie Li (Shenzhen) Cloud Technology Co., Ltd., Mr. Zeng Zhi, General Manager of Shenzhen Today Investment Data Technology Co., Ltd., and Ms. Chen Ying, Founder of Shenzhen Roadshow Zhong Network Technology Co., Ltd., respectively signed strategic cooperation framework agreements on behalf of Frost & Sullivan, cloud technology, today investment and roadshow zhong. The parties decided to create a one-stop cross-border IPO listing Establish long-term, stable, and close strategic cooperation relationships in service areas to jointly help more enterprises achieve cross-border IPO listing Escort and protect. The first day's main forum gathered a distinguished group of talents, shining with brilliance. With the participation of hundreds of attendees, it successfully concluded. Guests from institutions, enterprises, and universities showcased their expertise to both online and offline audiences. Together, they presented a splendid and unique feast of wisdom.   9 month 28 Today, the Biotechnology Investment Forum focused on new trends in biotech investment and financing. The exciting content continues. Stay tuned! About Frost & Sullivan Global GIL Summit The Frost & Sullivan Growth, Tech and innovation Leadership Summit has been launched globally with over 20 Countries and regions, with nearly 30 The event's history spanning over a decade has attracted a large global audience. 1000 Strong companies, top domestic and international financial institutions, and other leading enterprises are deeply involved, helping them identify opportunities, continuously innovate, accelerate growth, and gain a leadership position in an increasingly complex and changing world. 2008 Since its inception in China in 2010, the Frost & Sullivan Global Annual Conference on China has been held for sixteen sessions. GIL The summit has become an important platform for outstanding domestic enterprises, investment industry leaders, and regulatory authorities to exchange successful experiences and jointly discuss development directions. It is also a crucial window through which the world understands China's most cutting-edge development trends.

Analysis of the Current Situation and Future Trends of the Chinese Baking Market From September 19th to 22nd, 2022, the 24th China International Baking Exhibition opened at the Shanghai Hongqiao National Convention and Exhibition Center . The exhibition provides a platform for professionals in the global baking industry and various baking-related workers to share innovative ideas, injecting momentum into promoting the development of the baking industry in areas such as research and development, manufacturing and distribution, and related services, and facilitating the comprehensive development of China's baking sugar products industry.   Frost & Sullivan (Frost & Sullivan, abbreviated as "Frost & Sullivan") and Anjia Professional Dairy (AFP) jointly released a white paper - "Analysis of the Current Situation and Future Trends of the Chinese Baking Market in the Post-Pandemic Era" (hereinafter referred to as the "Report"). Zhang Jianjian, Partner and Managing Director of Frost & Sullivan Greater China, and Zhang Xiaojing, Executive Director of Greater China, delivered speeches at the exhibition site.   The report provides an in-depth interpretation from four perspectives: an overview of the baking industry, operational performance of baking enterprises, research and development analysis of baking enterprises, and consumer insights, exploring industry changes, channel potential, consumer concerns, and market opportunities under current circumstances, providing professional data and guidance for baking enterprises to innovate and upgrade, transform towards low carbon, expand markets, and conduct digital marketing.   According to Zhang Jianjian, in 2020, the retail sales volume of the Chinese baking market reached approximately 250 billion yuan, and in 2021 it reached about 280 billion yuan, with great growth potential in the future. In recent years, the continuous improvement of urbanization rates, disposable income, and purchasing power have promoted the continuous penetration of the baking market, thereby driving up per capita consumption expenditure on baked goods.   With consumption upgrading and the increasing acceptance of Western lifestyles and dietary cultures by young consumers, the consumption of baked goods has developed towards diversification and high-end, promoting continuous innovation and improvement in the baking industry. On the other hand, with the popularization of digital marketing across all platforms and takeaways, the number of transaction users has significantly increased, reaching a wider consumer base while also bringing about a double increase in revenue and operational efficiency for baking brand owners, boosting the further development of the baking market. Zhang Jianjian, Partner and Managing Director of Frost & Sullivan Greater China   Zhang Xiaojing stated that the pandemic has had many impacts on baking enterprises. From the enterprise side, after the outbreak of the pandemic, baking enterprises have paid more attention to digital innovation and upgrading in terms of products, channels, and marketing, such as launching online limited products, self-built online ordering platforms, live streaming sales, etc. At the same time, the proportion of online channel income has increased significantly. From the consumer side, consumers have significantly increased their attention to food quality and safety when purchasing baked goods. Zhang Xiaojing, Executive Director of Frost & Sullivan Greater China   The report points out that the Chinese baking industry shows the following five development trends: 1) Baking products are becoming more diverse, healthy, snack-like, and interesting to meet the changing needs of young consumers; 2) Baking enterprises are committed to researching and selecting higher-quality raw materials and functional and nutritious ingredients to organically combine with baked goods; 3) Multi-channel digital marketing + live streaming, online consumption have become new marketing trends; 4) Diversification of baking channels: New Chinese-style baking leads industry growth, new baking cross-border forces continue to expand; 5) Under the "carbon peak" and "carbon neutrality" plans, it is expected that the Chinese baking industry will gradually implement low-carbon production concepts starting from the upstream in the future.   According to Frost & Sullivan research, the R&D trends of Chinese baking enterprises include youthfulness, product innovation, seasonal R&D, baking black technology, industrialization 2.0, low carbon environmental protection, etc.   Youthfulness To meet the needs of the main consumer group, Generation Z, the interviewed leading baking brands focus on upgrading product appearance, trendiness, and healthiness, aiming to make baked goods a "fashionable" carrier in young people's consumption.   Product Innovation Consumption upgrading has prompted the interviewed enterprises to raise requirements for food raw material R&D iteration, product diversity, taste, functionality, etc.; Chinese-style baking categories are rich and diverse, and in recent years, new Chinese-style baking brands and trendy styles have emerged, becoming one of the main growth points in the baking industry.   Seasonal R&D Developing seasonal limited or festival-exclusive products using fresh seasonal ingredients is the focus of seasonal R&D for the interviewed baking enterprises; mooncakes, as traditional Chinese seasonal baked foods, are a key category for seasonal baking R&D, with the overall market scale maintaining a slight increase, leading brand sales growing, and room temperature mooncakes remaining mainstream.   Baking Black Technology With consumers' increasing demand for the functionality of baked products, "black technology" raw materials such as lactic acid bacteria, probiotics, and collagen have become another possibility for new product R&D.   Industrialization 2.0 The overall industrialization level of the baking industry will continue to improve in the future, and industrialization 2.0 represented by industrialized semi-finished production + store baking/decoration is expected to be the optimal solution to balance product production efficiency and quality;   Low Carbon Environmental Protection The baking industry will actively respond to the "14th Five-Year Plan," incorporating low carbon environmental protection into the consideration criteria for raw materials and processes; in the baking industry, the key links for low carbon environmental protection are the upstream livestock industry and production process, and leading enterprises in the industry have carried out relevant carbon neutrality research regarding their carbon emissions.   The fourth part of the report focuses on consumer insights, comprehensively analyzing the consumption psychology and habits of baked food consumers from perspectives such as consumer profiles, main consumption purposes of baked foods, main consumption scenarios and time periods, preference for shelf life, purchase channels, single purchase price range and frequency, preferences for the taste, texture, flavor, and functionality of baked foods, and consumers' awareness of dairy fat and plant-based fats.   1) From the perspective of consumers' age, gender, occupation, and average monthly family income, The main consumer groups for baked foods are post-90s and post-00s, female consumers, students, and white-collar workers, with an increasingly younger age structure in recent years; about 64% of consumers have an average pre-tax monthly income exceeding ten thousand yuan.   2) From the perspective of preference for shelf life, Consumers prefer fresh and short-shelf-life baked foods, with more than half of consumers choosing to eat on the same day or within a short period when selecting among bread, cake, and snack baked foods. The concept of fresh food in the baking consumption market is significant, and consumers tend to buy more snack baked foods when purchasing baked foods with a relatively longer shelf life.   3) From the perspective of purchase channels, In the post-pandemic era, leading baking enterprises have strengthened their online ordering systems, with a significant growth rate in online channels, mainly reaching consumers through e-commerce platforms and takeaways. The overall online channel purchase proportion of baked foods is about 30%; currently, offline chain bakeries are still the main purchase channel for baked foods.   4) From the perspective of preferences for the taste, texture, flavor, and functionality of baked foods, Consumers generally prefer baked foods with fruit flavors, soft and glutinous textures, and richer milk flavors; and in an increasingly health-conscious era, consumers prefer lower-sugar baked foods, with varying degrees of attention paid to functional raw materials such as high fiber, high protein, high calcium, and trace elements. A product matrix that combines taste *texture* flavor *functionality* is conducive to empowering product innovation and fission.   5) From the perspective of consumers' awareness of dairy fat and plant-based fats, More than 60% of consumers are familiar with the differences between dairy cream, vegetable cream, mixed cream, as well as animal butter, margarine, and mixed butter. The awareness of dairy fat among consumers has basically been popularized. More than 70% of consumers pay attention to and prefer purchasing baked foods using dairy fat. As consumers' awareness of dairy fat gradually deepens, along with consumption upgrading and the addition of health dietary concepts, the use of dairy fat will become mainstream and the norm in the industry in the future.    

The high-end equipment manufacturing industry is a strategic emerging industry led by high-tech, located at the high end of the value chain and at the core of the industrial chain. It determines the comprehensive competitiveness of the entire industrial chain and is the backbone of the modern industrial system, as well as the engine for promoting industrial transformation and upgrading. This year's newly listed 279 In the company, over 90% come from strategic emerging industries, with high-end manufacturing becoming one of the distribution areas. 39 Total funds raised by enterprises 423 100 million yuan.   What are the reasons why the capital market has been strongly encouraging high-end equipment manufacturing enterprises to go public for financing in recent years? How can high-end equipment manufacturing enterprises make effective use of various financing tools available in the capital market? A Listed companies in the high-end equipment manufacturing sector face issues such as a relatively small number, low market value, and the need to further improve development quality. How should the capital market further enhance its service quality and efficiency? Frost & Sullivan Frost & Sull ivan, Mr. Lu Jing, Partner and Managing Director of Frost & Sullivan's Greater China Region, was interviewed by Securities Daily to discuss the future development of high-end equipment manufacturing enterprises in the capital market. Securities Daily Since the beginning of this year, capital has accelerated its flow towards the field of technological innovation. A number of listed companies with significant influence and strong innovation capabilities have emerged in the high-end equipment manufacturing industry, leading to the optimization and upgrading of the industry. wind Information data shows that since the beginning of this year, there have been 37 Home high-end equipment manufacturing company listing A Equity, mainly concentrated in the ChiNext and STAR Market sectors, widely covering industries such as mechanical equipment, national defense industry, and power equipment. The total amount of raised funds 423 Yuan, ranking among the top in the nine strategic emerging industries. "As a leading enterprise in high-end equipment manufacturing, listed companies need to leverage the capital market platform and flexibly use various tools of the capital market to develop and grow themselves." Xu Shaomei, Deputy General Manager and Secretary of the Board of Directors of Guoci Materials, told the Securities Daily reporter. On one hand, it is necessary to establish and improve the equity incentive system to attract high-end talents, enhance independent innovation capabilities, and boost the core competitiveness of the enterprise. On the other hand, it is essential to broaden direct financing channels, increase investment in research and development, provide guarantees for technological innovation, promote the autonomous control of the industrial chain, and drive the high-quality development of manufacturing.   The "Mass Entrepreneurship and Innovation" sector brings together high-performing enterprises Lead the high-quality development of industries In recent years, the capital market has continuously increased its efforts in supporting direct financing for high-end equipment manufacturing and facilitating technological innovation, achieving remarkable results. "At present, our country is at a critical period of economic structural transformation and upgrading. It is necessary to give full play to the role of capital markets, promote the coordinated development of direct and indirect financing, guide funds towards emerging industries such as high-end equipment manufacturing, meet the financing needs of relevant science and technology innovation enterprises at different stages of development, and further implement the innovation-driven development strategy," said Wang Weijia, general manager of Beijing Sunshine Tianhong Asset Management Company, to the Securities Daily reporter. As the main battlefield for capital markets to support the innovation-driven development strategy, the ChiNext and STAR Market have gathered a group of high-end equipment manufacturing enterprises, leading the high-quality development of industries. In terms of the ChiNext, data from the Shenzhen Stock Exchange show that as of this year 8 At the end of the month, the ChiNext has gathered a group of high-end equipment manufacturing companies that are deeply involved in multiple sub-sectors such as intelligent manufacturing equipment, aviation equipment, satellites and applications, industrial robots, rail transit equipment, and offshore engineering equipment. 114 Home, with total market value exceeding 1 trillion yuan. 2019 Year-end 2021 In [year], the average operating revenue growth rates of companies in the high-end equipment manufacturing industry on the ChiNext were 20.47% , 11.71% , 25.52% , with a compound annual growth rate for the period 15.78% In terms of the Sci-tech Innovation Board (STAR Market), public data shows that there are currently over a hundred companies in the high-end equipment manufacturing sector on the STAR Market, with fundraising exceeding one trillion yuan. As a high-end manufacturing company in China for semi-trailers and special-purpose vehicles, CIMC Vehicles has reaped many benefits after listing on the ChiNext. "Over the past year, CIMC Vehicles has further improved its governance structure. Leveraging the capital market platform, through the implementation of fundraising projects, the company has further built a high-end manufacturing system, promoting the automation, intelligence, and digitization of production," said Li Guiping, CEO and President of CIMC Vehicles, in an interview with a reporter from Securities Daily.     Promote the innovation-driven development of industries Accelerate the transformation and upgrading of manufacturing High-end equipment manufacturing is a strategic emerging industry that leads with high-tech, occupies the high end of the value chain and is at the core of the industrial chain. It determines the comprehensive competitiveness of the entire industrial chain and serves as an engine for promoting industrial transformation and upgrading. The capital market's role in supporting the development of high-end equipment manufacturing is of great strategic significance. It is conducive to promoting innovation-driven development and digital transformation of high-end equipment manufacturing, facilitating the autonomous control of industrial chains and supply chains, and accelerating the transformation and upgrading of manufacturing. "The high-quality development of our economy and the transformation and upgrading of manufacturing require multi-faceted service support from the capital market." Chen Li, chief economist and director of the research institute at Sichuan Finance Securities, said in an interview with a reporter from Securities Daily that currently, China's traditional mid- to low-end manufacturing has seen a decline in comparative advantages in production factors such as labor costs and natural resources. In contrast, neighboring countries have obvious cost advantages, which are forcing China's manufacturing industry to accelerate its transformation and upgrading. As the pace of industrial upgrading continues to accelerate, it also requires the assistance of the capital market. If financing If the supply cannot keep up in a timely manner, high-end equipment manufacturing will not be able to make breakthrough progress, which will also restrict the long-term development of the manufacturing industry. "   "Currently, a new round of technological revolution and industrial reform is entering a new phase. The capital market's support for high-end equipment manufacturing companies is mainly reflected in providing them with low-cost medium- to long-term funds using financial instruments and market platforms, thereby enhancing the competitiveness and innovation capabilities of these companies, overcoming bottlenecks, further promoting the transformation and upgrading of manufacturing, and improving the competitiveness of China's economic development," said Lu Jing, Partner and Managing Director of Frost & Sullivan Greater China, to the Securities Daily reporter.   Give full play to multi-level advantages Improve the quality and efficiency of capital market services Currently, listed companies in China's high-end equipment manufacturing industry still face issues such as a small number of companies, low market value, and the need to improve development quality. Listed companies need to fully utilize various market tools to strengthen themselves, and the service quality and efficiency of the capital market also need to be further enhanced. " "At present, most manufacturing enterprises rely on the banking system for indirect financing. Manufacturing enterprises have a longer capital turnover time and prefer to 3 Year to 5 Medium- and long-term financing for the year. At the same time, the financial support system that complements the rapid development of high-end equipment manufacturing companies is not perfect. Some high-quality high-end equipment manufacturing companies face difficulties in financing and can rely on the capital market to raise funds directly through various methods such as initial public offerings, additional share issues, and rights issues." Lu Jing said. Chen Li believes that by leveraging the market's resource allocation function, the capital market can screen out high-quality listed companies in the high-end equipment manufacturing industry, optimize various market sectors, form a 'stepped' multi-level market system, establish a development model corresponding to the levels of enterprise development in the capital market, and continuously improve the quality of services provided to companies in the high-end equipment manufacturing industry. " Lu Jing stated that the capital market should improve its service matrix and enhance its service capabilities, encourage more high-quality high-end equipment manufacturing companies to carry out investment and financing activities, and provide comprehensive high-quality services for enterprises. It is necessary to fully leverage the resource allocation function of the capital market to help enterprises develop sustainably, healthily, and rapidly, and to promote the industry into a new stage of high-quality development.   * This article is reprinted from Securities Daily, reporter    Xing Meng    ,    Original title:    The capital market boosts the innovation-driven development of high-end equipment manufacturing “mass entrepreneurship and innovation” sectors, with a prominent agglomeration effect.    ">

The Greater Bay Area Carbon Neutrality Association is chaired by Mr. Hu Bojie, Vice Chairman and Executive Director of Peiran Environmental Consulting Co., Ltd., Mr. Xu Zhuliang, Chairman of the Board of Directors of Jinshan Energy Group, Ms. Wu Min, President of Huaery Golden Control Group, Mr. Geng Guohua, Executive Director and Chief Executive Officer of Aidi New Energy Investment Holdings Group, and Frost & Sullivan ( Frost & Sullivan Initiated jointly by Dr. Wang Xin, Global Partner and President of Frost & Sullivan Greater China, the initiative aims to build a closer network within the region, gather talents from all sectors of society, and promote cross-sectoral cooperation in academia, innovation, finance, etc., with the hope of collectively achieving carbon neutrality. The association was established in 2021 year 12 month 10 Established on January 1st, within just over nine months, it has received high attention from the Hong Kong Special Administrative Region and various cities in the Greater Bay Area. It has connected with a large number of resources to offer strategies for the country to achieve the "dual carbon goal" at an early date.   To express our gratitude to all core members and think tanks for their contributions, the association held 9 month 21 The event was held at the Central Plaza, where a banquet was arranged for gathering together. Experts were also invited to share their opinions and plan for the one-year anniversary celebration and the work for the coming year. Mr. Liu Zeheng, the consulting director of Frost & Sullivan Greater China, was honored to attend the dinner. At the dinner, Mr. Yue Yi, Honorary President of the Greater Bay Area Carbon Neutrality Association, Director of the Greater Bay Area Research Center, former Vice Chairman, Executive Director and President of Bank of China Hong Kong (Holdings) Limited, Mr. Liu Zhiming, Deputy Secretary-General of the China Invention Association, Professor Hong Weimin, a National People's Congress delegate and former Chief Liaison Officer for Hong Kong Affairs of the HNA Administration, Mr. Zhang Bin, President of the China-Hong Kong Culture Association, Professor Zhang Qin, Executive President of UNESCO Association, Ms. Zeng Lingyi, host and producer of the Phoenix TV's "Jinshi Finance" program, and other experts and scholars offered their opinions and suggestions on the association's work.   Mr. Yue Yi, Honorary President of the Greater Bay Area Carbon Neutrality Association, put forward suggestions   Mr. Liu Zhiming, Deputy Secretary-General of the China Invention Association, invited the association to participate in the selection of carbon neutrality projects in Foshan   Professor Hong Weimin, a deputy to the National People's Congress and former Chief Liaison Officer for Hong Kong Affairs at the Hong Kong and Macao Affairs Bureau, suggested that the association raise awareness among young people in Hong Kong and Shenzhen about carbon neutrality Mr. Zhang Bin, President of the China-Hong Kong Culture Association, pointed out that carbon neutrality can also be reflected through cultural exchanges   Professor Zhang Qin, Executive President of UNESCO Associations, pointed out that the goal of carbon neutrality is in line with the United Nations    17    an    SDGs    Highly compatible, allowing for joint promotion   Mr. Hu Bojie, Founding President of the Greater Bay Area Carbon Neutrality Association, Mr. Xu Zhuliang, Vice President, Ms. Guo Meiheng, Vice President, Ms. Wu Min, Vice President, Ms. Luo Qiping, Secretary-General, Mr. Wen Zhuofei, Vice President, Ms. Mai Huang Xiaozhen, Honorary Strategy Advisor, and Dr. Shao Zhiyao, Director of the Council, listened attentively to the suggestions of the think tank and will implement them in their work next year.   Mr. Hu Bojie, Founding President of the Greater Bay Area Carbon Neutrality Association   Mr. Xu Zhuliang, Vice President of the Foundation   Ms. Wu Min, Vice President of the Founding Council    (    right    )    Consulting Director of Frost & Sullivan, Liu Zeheng   The attendees are industry leaders, and they offered suggestions to the association during the event   Dr. Wang Xin, Global Partner and President of Greater China at Frost & Sullivan, stated that the firm has been continuously focusing on green investment and has produced a large number of forward-looking reports on green industries, guiding investors to focus on China's green sector. Green venture capital is an important lever for China to implement its carbon neutrality goals. Carbon neutrality is a catalyst for accelerating China's energy transformation, improving the ecological environment, and enhancing the quality of life. In the future, Frost & Sullivan will continue to focus on carbon neutrality and fully support the country in achieving its carbon neutrality targets. About the Greater Bay Area Carbon Neutrality Association The association is a non-profit organization composed of scientific research institutions, universities, industry experts, funds, financial institutions, media, groups, enterprises, and individuals who support environmental protection and carbon neutrality. Its purpose is to provide members with services related to carbon neutrality, including environmental protection, emission reduction, design, consulting, evaluation, certification, rating, valuation, expert opinions, talent training, academic and industry exchanges, introduction and exchange of new technologies, international promotion and exchange, joint project research and development, project delivery and implementation, green finance and capital market operations. It is committed to promoting the transformation of the green carbon neutrality industry in the Greater Bay Area, advancing the development of green technology, actively developing the green finance and carbon trading markets in the region, and taking the lead in promoting carbon neutrality and development in various districts based on the advantages of the Guangdong-Hong Kong-Macao Greater Bay Area. It aims to contribute to the country's climate change commitments and influence the world.

2022 year 9 month 20 day -21 On the day, co-hosted by the China Pharmaceutical Business Association, the China Chemical Pharmaceutical Industry Association, the China Traditional Chinese Medicine Association, and Sinopharm Exhibition & Convention Co., Ltd., “ 2022 The 'China Healthcare Leaders Summit & China Pharmaceutical Distribution Industry Supply-Side Structural Reform and Innovation Forum' was held in Shanghai. With the theme of 'Revitalization & Symbiosis', this conference conducted a profound analysis and interpretation of aspects such as 'the reform of the medical security system during the 14th Five-Year Plan period' and 'opportunities and challenges brought by deepening healthcare reform to the market'; it also explored in depth the differentiated business layout of enterprises and the innovative changes in the pharmaceutical supply chain; and analyzed and assessed the future development trends of the pharmaceutical distribution industry in areas such as medical devices, innovative high-value drugs, and special medical foods. Frost & Sullivan Frost & Sullivan Li Qian, Senior Consulting Director for Healthcare in Greater China at Frost & Sullivan (referred to as 'Frost & Sullivan'), was invited to attend the conference and delivered a speech on the analysis of the Chinese healthcare market and popular sectors. Senior Consulting Director, Healthcare, Frost & Sullivan Greater China Li Qian   Li Qian pointed out that after entering the '13th Five-Year Plan' period, China has elevated 'Healthy China' to a national strategy, and the big health industry has begun to develop rapidly.    Data shows that the market scale of China's big health industry 2017 year 6.52 trillion yuan, increasing to 2021 year 9.23 trillion yuan 2017 - 2021 year after 9.1% The annual compound growth rate has been rapidly accelerating. Among them, the proportion of the medical service market 56.4% It is the largest sub-market within the large health market segmentation field.   In recent years, the large health market has gradually differentiated. Apart from the medical services market, which is the largest in scale, the markets for medical devices and consumer healthcare have grown relatively rapidly.   It is expected that under the trends of a beauty economy and enhanced residents' purchasing power, residents' demand for healthcare products and services with stronger consumer attributes will continue to increase. In the future, the demand in the consumer healthcare market will be further unleashed.   According to a study by Frost & Sullivan, driven by favorable policies and residents' health needs, China's large health industry structure has been gradually optimized. Under the current policy orientation of healthcare cost control and import substitution, domestic innovative drugs and medical devices are developing rapidly. At the same time, capital from home and abroad pouring into China's large health market will accelerate the development of emerging fields such as innovative drugs, consumer healthcare, and digital healthcare.   In the future, China's large health market will develop into an industrial model led by technology and products, with services as an important means.   Subsequently, Li Qian focused on the popular segment of consumer healthcare - the medical aesthetics market. Consumer healthcare is a competitive sector that combines 'consumption' and 'medical' attributes. Li Qian believes that under the general trend of consumption upgrading, there is a vast potential consumer base in the consumer healthcare market. 2017 - 2021 The annual compound growth rate of the consumer healthcare market is 15.5% , 2021 Nearly reached 9 One trillion yuan.   The consumer healthcare market is primarily targeted at young people and high-income groups. Consumers expect to improve their appearance and health through consumption of healthcare products. The entire consumer healthcare market exhibits high average transaction value per customer, high profit margins, and Finally, Li Qian summarized the future development trends of the medical aesthetics industry. She stated:    1 With stricter regulation and industry integration, the medical beauty market will return to formal institutions and projects in the future, leading to a healthier and more orderly development of the industry;    2 )    Consumers' understanding of medical aesthetics will gradually deepen, and their consumption decisions will become more mature and rational. They will tend to choose professional medical aesthetic institutions that are regular in operation, provide high-quality services, and have a good reputation;    3 With the large-scale growth of the medical beauty market, specialized medical beauty institutions and departments will develop rapidly, providing consumers with more professional, comprehensive, and full-cycle medical beauty solutions;    4 The continuous iteration of non-surgical medical aesthetics technologies has provided consumers with diverse choices, helping institutions develop highlight projects, acquire customers, and accelerate expansion. Non-surgical medical aesthetics projects will redefine the medical aesthetics market.   "The market will be further standardized under the impetus of strong supervision, and in the future, it will provide consumers with more professional and diversified services." Li Qian said. Characteristics of dependent marketing.   In the entire consumer healthcare market, the medical aesthetics market has a large scale and rapid growth rate. Among them, non-surgical medical aesthetic projects are gradually favored by consumers due to their low unit price, minimal trauma, short recovery period, and low risk. The attribute of repeat consumption makes the market demand huge, thus leading to rapid growth in the market share of medical aesthetics. Data shows the scale of China's medical aesthetics market 2017 - 2021 The compound annual growth rate reaches 17.5% Among them, the market scale of non-surgical medical beauty projects achieved a compound annual growth rate of 24.9% , is expected to arrive 2026 The year will grow to 4 one trillion yuan 2030 Year is coming 6.4 One trillion yuan.   "With the implementation of various policies, the medical aesthetics industry has entered an era of strong regulation. In the future, a sound regulatory mechanism will promote the standardized and rapid development of the market."    Li Qian further explained, 2021 In [year], eight departments including the National Health Commission issued the 'Notice on Printing and Distributing the Special Rectification Work Plan for Combating Illegal Medical Beauty Services', launching a nationwide special rectification campaign against illegal medical beauty services. This campaign aims to severely crack down on activities related to illegal medical beauty, standardize medical beauty services, and combat the illegal production and sale of drugs and medical devices. In the same year, the State Administration for Market Regulation issued the 'Medical Beauty Advertising Law Enforcement Guidelines (Draft for Soliciting Opinions)', requiring the rectification of various medical beauty advertising anomalies, focusing on solving problems that pose significant hazards and are highly reflected by the public, and strictly regulating the endorsement behavior of industry personnel. Finally, Li Qian summarized the future development trends of the medical aesthetics industry. She stated:    1 With stricter regulation and industry integration, the medical beauty market will return to formal institutions and projects in the future, leading to a healthier and more orderly development of the industry;    2 )    Consumers' understanding of medical aesthetics will gradually deepen, and their consumption decisions will become more mature and rational. They will tend to choose professional medical aesthetic institutions that are regular in operation, provide high-quality services, and have a good reputation;    3 With the large-scale growth of the medical beauty market, specialized medical beauty institutions and departments will develop rapidly, providing consumers with more professional, comprehensive, and full-cycle medical beauty solutions.    4 The continuous iteration of non-surgical medical aesthetics technologies has provided consumers with diverse choices, helping institutions develop highlight projects, acquire customers, and accelerate expansion. Non-surgical medical aesthetics projects will redefine the medical aesthetics market.   "The market will be further standardized under the impetus of strong regulation, and in the future, it will provide consumers with more professional and diversified services." Li Qian said.

Chinese Cosmetics   . China Cosmetics magazine is a professional and authoritative media in the cosmetics industry supervised by the China Federation of Commerce, with an internal publication number. CN:11-3013/Ts International ISSN ISSN:1004-5163 . In recent years, due to the improvement of residents' income levels in China, their pursuit of quality of life, enhanced health awareness, and consumption upgrading, skincare products have become a highly concerned area among Chinese consumers. As the cleaning cosmetics with the largest consumption volume and essential items for daily life in the Chinese cosmetics market, skincare products still have great sales volume and development potential.   Frost & Sullivan Frost & Sullivan, Xie Weirong, a consulting analyst at Frost & Sullivan's Greater China region and the author of an article on the domestic skincare market format for China Cosmetics magazine, discussed the current situation and future development trends of the domestic skincare market. China Cosmetics Magazine   author   | Xie Weirong   Frost & Sullivan consulting analyst In recent years, due to the improvement of residents' income levels in China, their pursuit of quality of life, enhanced health awareness, and consumption upgrading, skincare products have become a highly concerned area among Chinese consumers. As the cleaning cosmetics with the largest consumption volume and essential items for daily life in the Chinese cosmetic market, skincare products still possess great sales potential and development prospects. Ten or even five years ago, the largest share of the personal care market was held by international daily chemical giants such as Procter & Gamble, Unilever, and L'Oréal. and 2020 At the beginning of the year, a sudden COVID-19 pandemic (COVID-19) Rapidly spreading globally, in response to the government's call for self-quarantine at home, the method has driven the rise of the live streaming e-commerce industry. The emergence of WeChat business and e-commerce has begun to transform the domestic skincare market ecosystem. Development History and Current Situation of the Chinese Personal Care Market The development of China's personal care industry began at 20 century 60 The era roughly went through four stages: The first phase is the initial cleaning era, The national income level is low, and the domestic consumer goods market is limited. The hair care industry has not received widespread attention. In the early years, people mainly used basic products such as soap, shampoo, and conditioner to clean their hair; The second phase is the infancy of skincare products, 70 At the end of the decade, the concept of separating shampoo and conditioner was promoted, leading to the birth of China's first shampoo - Fenghua Shampoo. The third phase is the era of rapid development for skincare products, International companies Procter & Gamble and Unilever have begun to enter the Chinese market and quickly took a leading position. As the market share of international daily chemical companies has been climbing year by year, domestic shampoo and care manufacturers have realized the development potential of this industry and started to gradually make progress, but there is still an obvious gap; The fourth phase is the era of comprehensive cleansing and care. To meet consumer needs, major brands have launched comprehensive skincare products that satisfy various aspects of consumers' demands from the perspectives of ingredients and efficacy. Since then, the Chinese skincare market has entered a period of full-scale development and prosperity, with domestic brands led by Adore leading the way into the mid-to-high-end market. at 2020 At the beginning of the year, a sudden COVID-19 pandemic COVID-19 pandemic Affected by this, the washing and care industry has entered a new development era. Local enterprises are increasingly gaining market share in the washing and care industry due to their advantages in e-commerce channels and functional and technological innovations in product quality. Secondly, with 90 later, 00 Gradually, they entered the workplace and became the main consumers in the shampoo and hair care industry. High-intensity work pressure, anxiety, irregular diet, staying up late, and other habits have made consumers increasingly value the safety and functionality of cleaning and conditioning products. Simple cleansing and conditioning combinations can no longer meet the needs of the younger generation. 1. The industry scale is growing rapidly, with shampoo products taking a dominant position; consumer demand is segmented, and domestic brands in the skincare industry are emerging. Currently, it is in an upward phase at the mid-to-high-end level. The increase in per capita disposable income has enhanced consumers' purchasing power and promoted consumption upgrading. People are beginning to pursue a higher quality of life, which has strongly driven the development of China's washing and grooming market. In the current era of the beauty economy, hair is also regarded as a person's 'second face' for care, and consumers are paying more attention to their own hair quality and hairstyle. In recent years, the market scale of personal care products in China has continued to grow. According to JD.com data statistics, 2021 The market scale of China's personal care industry in 500 Hundreds of millions, 2016 Year-end 2021 The annual compound growth rate for the year is about 6% left and right. Currently, in the domestic washing and care market, shampoo and hair care products still account for the vast majority of market share. Among them, shampoo products occupy the largest market share. According to a study by Frost & Sullivan, 2021 In the Chinese shampoo and hair care industry market in 40% , 34% Left and right. The proportion of hair growth share is relatively small, but in recent years, due to the fast-paced life pressure, people's attention to preventing hair loss has been increasing. It is expected that the market share will gradually increase year by year in the future. Source: Frost & Sullivan research   2021 The market scale of Chinese shampoo products in China was approximately 200 Hundreds of millions, with the market scale growing steadily year by year. As the main product in the industry, it is predicted that its market share may remain stable and slightly decline in the future. This is because the incremental market mainly lies in more segmented care and hair styling products. 2022 Year to 2027 The annual compound industry growth rate may be at 3% The range fluctuates, expected 2027 The market scale of Chinese shampoo products may reach 270 About 100 million yuan. Source :Frost & Sullivan research   Due to the increasing popularity of health care and skincare separation models, consumers' attention to hair care products has also been rising year by year. According to LeadLeo's data research, consumers' preference for mid-to-high-end hair care brands is becoming more evident. 2017 The import volume soared rapidly from the beginning of the year to 2020 The import value of hair care products reached nearly 9 billion dollars. Although leading skincare brands are still overseas ones, domestic brands are showing a strong momentum. Relatively speaking, domestic manufacturers understand better the habits of Chinese people, their skin conditions, and product demand trends, thus laying a good foundation for the development of the functional skincare market for domestic products. According to LeadLeo's data research, recently 40% Consumers in 2021 In recent years, consumers have shown a greater preference for domestic brands, and the proportion of those with a strong intention to purchase imported brands is declining year by year. Under the combined influence of internal factors such as high anxiety and stress, greasy diets, and staying up late, as well as external factors like frequent dyeing and perming, inadequate care, consumers' hair and scalp health are affected to varying degrees. This has led to a series of common hair problems including dandruff, scalp itching, oily or dry split ends, and more. This has led to consumers having more diverse needs for skincare products, evolving from basic cleansing capabilities to those with additional effects such as oil control, anti-dandruff, fullness and softness, smoothness, dandruff removal and itch relief, soothing properties, scalp care, and long-lasting fragrance. Therefore, the attractiveness of ordinary cleaning and care products to consumers has begun to decline, with consumers preferring to purchase mid-to-high-end functional cleaning and care products to meet their specific needs. Mid-to-high-end skincare products are a sub-category that goes beyond basic cleaning capabilities, offering further enhancements. The difference between them and mass-market skincare products is not just in price disparity; the premium nature is mainly reflected in optimized innovation designs for product quality, ingredient additions, and packaging. According to preliminary data statistics, from 2017 Since the beginning of the year, there has been a clear trend of market consumption upgrading in the domestic skincare industry. Consumers' ability to purchase mid- to high-end skincare products has improved, and their demand for product grades has risen. Among them, the market scale of high-end skincare products is growing at a rate of approximately 20% As mentioned above, the market scale growth rate of mass shampoo and hair care products is relatively slow, but the market scale still maintains a stable growth trend. Although the scales of the two are 2020 Affected by the pandemic, they have all decreased, but are expected 2021 The annual growth rate of product scale in the mass shampoo and hair care market may reach 8% Left and right, while the growth rate of product scale in the high-end shampoo market may be at 24% left and right. Source :Frost & Sullivan research   According to JD.com's 2022 The "Personal Care Trend Report" shows that consumers are clearly showing a trend towards purchasing high-end brands, with product sales year-on-year growth exceeding 90% The sales speed of the high-end line has even reached 114% Among them, after Kaisi opened its official flagship store on JD.com for one month, both its search traffic and recommended traffic from the self-operated store quickly ranked TOP Level. Second, consumers' demand for skincare products is no longer limited to traditional basic cleansing. Affected by consumption upgrading and demand segmentation, functional skincare products that can solve multiple skin problems are favored by consumers, with a significant increase in consumption proportion. The growth rate is higher than the overall daily chemical skincare market, indicating a promising future development prospects for the market. Functional skincare is a type of product that adds specific ingredients to regular cleansing and care products to help solve specific problems with hair or skin. The functional skincare industry in China has been 1980 The budding period of the year has begun, and it has continued to this day 40 Over the years, it has gone through four main stages: the budding period, the development period, the fluctuating period, and the mature period. The germination period is in 1980 Around Many time-honored brands on the market today were born during this period, such as Fenghua and Meijiaojing, but most of the functional skincare products in their infancy were low-end products. The influx of multiple international daily chemical company brands has squeezed the market share of local brands, leading to their closure. Subsequently, the market entered a development and volatile period. During this period, the market characteristics were that domestic brands dominated the mainstream, while overseas brands took the lead in localized development. 21 Since the beginning of this century, the functional skincare industry has entered a mature phase. This phase is influenced by the refinement of consumer demand, with a continuous emergence of various new products such as scalp cleansing care and scalp serums. With the improvement of living standards, consumers' disposable income has increased, driving consumption upgrades. Ordinary skincare products have lost their appeal to consumers, and hair and scalp problems such as oiliness, hair loss, dryness, and dandruff are becoming more frequent. The consumer group is more inclined to choose skincare products with specific functions that can solve their needs, mainly focusing on products with functions such as oil control, anti-dandruff, softening, repair, and moisturizing. According to LeadLeo's data research, the market scale of functional skincare products in China is 2016 - 2020 The annual compound growth rate may reach 5% Left and right. Currently, it occupies a significant market share globally and is still growing steadily. With the COVID-19 pandemic being well controlled and the domestic economy beginning to recover, the functional skincare industry may see a second wave of rapid development in the future. Secondly, with the increase in economic income and continuous improvement of education levels, the female consumer group in China has become a new force in the consumer industry. According to its statistics, among Chinese online functional skincare product consumers 60% Women account for the majority of the market on both the left and right sides, while their male consumer performance is also relatively impressive. According to Alibaba Health data and LeadLeo research, men's consumption growth rate in hair loss prevention products is the fastest. Female consumers, when purchasing functional skincare products, place more emphasis on packaging aesthetics and innovative designs, which are one of the important factors influencing their decision-making on whether to buy. According to the data from LeadLeo Research Institute, functional skincare products can be divided into two main categories: hair cleansing products and scalp care products. hair cleansing products It occupies the main sales share in the skincare market, and overall demand is quite widespread. Products with functional effects such as anti hair, dandruff removal and itching relief, scalp rejuvenation, and damage repair are showing a good growth trend, responding to the young people's need for 'anti hair, moisturizing and soothing' under the influence of stress and staying up late habits, becoming hot-selling products. Scalp care market The scale of 'LeadLeo', which is relatively smaller compared to the shampoo market, has seen the fastest annual growth rate according to LeadLeo's data. Scalp care is an emerging concept product in recent years, mainly aimed at conditioning the scalp skin rather than improving or repairing hair quality. Its product diversity covers all aspects, such as scalp cleansing, scalp activation, balancing the microbiota, nutritional care, and a series of other products. Under the cultivation of skincare products, in pursuit of keeping up with trends and the times, the scale of hair care products has also been expanding year by year. Moreover, the demographic distribution of hair care consumers is broader and more diverse, including both older and younger consumers who have issues covering white hair and hair loss, as well as those with the demand for trendy dyeing. However, the majority are hair dye products. Under the impact of the pandemic, home hair dyeing has sparked a craze, with consumers' enthusiasm for DIY increasing significantly. According to JD.com reports, the transaction volume of hair dye products accounted for 2021 Approximately half of the market for year-round dyeing and perming wigs is made up of 'home dyeing' products, while the volume of social media posts about 'home hair dyeing' has nearly doubled. Among these, products with natural plant ingredients that are safe, non-irritating, gentle, and have a dyeing and conditioning function are favored by consumers; products that offer optimized experiences and convenient operations are chosen by more people. Driving factors for the development of China's functional skincare market ·            Enhanced purchasing power and consumption upgrading   The increase in per capita disposable income has enhanced consumers' purchasing power and promoted consumption upgrading, thereby facilitating the development of China's functional skincare market. It has evolved from basic cleaning functions to today's 'skin care-style' hair care models. Comprehensive maintenance has become the choice of more and more consumers, with meticulous care from scalp, root, tip to color not allowed for error. ·            The rise of health-conscious washing and grooming habits and the diversified demand for products   With economic growth, awareness of personal care and health has been continuously increasing, and China's per capita expenditure on personal care products has steadily risen.   According to data from LeadLeo Research Institute, about 90% Consumers believe that shampoo and conditioner should be used in the same way as skincare, with products tailored to different hair types for corresponding effects. Currently, driven by the needs of Chinese consumers, in addition to mainstream functions such as deep cleansing and strengthening hair quality, new sub-categories have emerged for stabilizing the scalp, protecting against hair loss, soothing and repairing, and controlling oiliness. ·            Rapid growth in e-commerce and digital marketing   With the development and expansion of different sales channels, various skincare products are becoming more recognizable to consumers nationwide, leading to an increase in product consumption frequency. and Z Generations of widespread internet use have accelerated the promotion of digital marketing campaigns, driving the development of the feature-rich skincare market. Traditional sales channels KA Channels, such as specialty stores, will continue to be important sales channels for skincare products (especially high-end ones). ·            Technological innovation and enhancement   Advanced technology is crucial for the upgrading and innovation of skincare products.   For example, mature technology has enriched product styles and achieved significant efficacy in products such as scalp serums and anti-aging care; the integration of plant extracts, expensive medicinal materials, and other nutritional elements into products is increasing day by day. As more consumers choose to use professional skincare products, the rapid growth of technology supports the continuous development of China's overall functional skincare market. Future development trend of China's functional skincare market ·            Product features tailored to specific consumer segments   Under high-intensity work pressure and a fast-paced lifestyle, consumers are experiencing more pronounced phenomena such as hair loss and baldness.   According to data from the National Health Commission, the number of hair loss patients in China is as high as approximately 2.5 Hundred million people, among whom the number of men with hair loss is relatively large, about 1.6 Hundreds of millions account for the hair loss population 65% Left and right, and the population experiencing hair loss is showing a trend towards younger age groups. The increasing awareness among Chinese people to protect their hair volume through upgraded washing and care has driven the development of the anti-hair loss shampoo market. Under the huge demand for anti-hair loss products, various hair care products for preventing and nourishing hair have emerged.   According to LeadLeo data, 2016 - 2020 In China, the annual compound growth rate of the minoxidil market scale is as high as 20% Left and right. The continuous growth in the market scale of minoxidil proves the ongoing rise in the number of hair loss patients in China.   According to JD Supermarket data, in terms of skincare efficacy, blue ocean anti-dandruff products have become one of the main consumer trends. The number of users and sales of anti-dandruff products have seen rapid year-on-year growth. ·            Enhancement of consumer safety awareness   The frequent occurrence of consumer safety issues has made consumers pay more attention to added ingredients in products in recent years, with many turning pale at the mention of 'chemicals'. As a result, products containing natural ingredients (plant extracts) and silicone-free oils are receiving increasing attention from consumers, driving the development of the functional skincare market.   According to LeadLeo research data, Chinese skincare products Top 5 Among the natural ingredient types, sulfur and sea salt rank among the top two favored by consumers. Secondly, according to JD.com data, hyaluronic acid and plant extracts (phytopreparations) have become one of the main consumption trends, with a significant year-on-year increase in transaction volumes for soothing and scalp anti-aging products.   Additionally, among shampoo products, those that rank in the top three in sales also contain hyaluronic acid and plant extracts. Finally, silicone oil usually refers to dimethylsiloxane, which is primarily used as a sealant. Although it can help smooth hair texture, this chemical substance can cause serious harm such as hair loss.   Therefore, according to LeadLeo data, many skincare brands have launched silicone-free products, such as Pantene, Paris Olé, and Adore. ·          Preference for comprehensive skincare product matrix   With the development of the skincare industry, comprehensive skincare products (including basic and professional ones) will continue to increase in volume.   In the future, skincare products are expected to be more diversified, innovative, and upgraded. 2 - 3 The use of efficacy washing and care products, as well as set packages for one wash and one care, has become routine. Consumers will also need multi-functional washing and care products to effectively prevent and treat issues such as hair loss and scalp aging. This is also conducive to the development of leading enterprises with strong R&D capabilities and industry experience. ·          The rise of domestic brands and diversified channels   Affected by the pandemic, the emergence and rapid development of e-commerce and live shopping have driven the rise of domestic brands, leading to more diverse consumer choices.     The penetration rate of high-end skincare products in specialty stores and comprehensive commercial businesses has also been increasing year by year, thereby expanding the diversification of skincare market channels. Leading domestic skincare brands are better aware of the demand trends of Chinese consumers and offer suitable price ranges, which can help them build stronger market competitiveness.   III. The supervision of new policies in the skincare industry will also make its industry requirements more stringent and standardized in the future, enhancing consumer confidence and purchasing power.   The upgrade of supervision in the personal care industry not only reflects a gradual standardization and maturity of the industry, but also provides necessary basis for its development. It also implies continuous innovation and enhancement of technical capabilities, continuous improvement of technical standards, which enhances consumers' motivation and security in the personal care market, and lays a good foundation for future development. The International Agency for Research on Cancer (IARC) of the World Health Organization, which is published by the National Medical Products Administration of China, lists dioxins as 2B Class 2 carcinogens have the potential to cause cancer in humans. It is necessary to ensure the safety of the product, which does not contain dioxins. 2020 In [year], the State Council passed and issued the "Regulations on the Supervision and Administration of Cosmetics", which came into force in 2021 year 1 It came into effect from the beginning of this month. Article 16 of Chapter II of the 'Regulations' clearly classifies special cosmetics and ordinary cosmetics. Ordinary cosmetics, such as shampoos and hair care products, usually only achieve basic effects such as cleaning and increasing hair softness, and do not have therapeutic effects for symptoms like hair loss or regrowth.           2    021 In 2019, the National Medical Products Administration issued and implemented the 'Cosmetic Label Management Measures', which clearly stipulate that medical terms and descriptions of medical functions and effects should not be used in cosmetics advertising, such as hair regrowth, sterilization and antibacterial properties, traditional Chinese medicine prescriptions, etc.      * This article is published in the magazine China Cosmetics   ,   author    Xie Weirong    ,    Original title:    The growth rate of high-end products has been remarkable, and the logic of the shampoo and care market has changed.    ">